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Objective: Managed care practices that limit access to and duration of treatment conflict with 
established standards of care for patients with anorexia nervosa (AN).  However, there is little 
information about how abbreviated lengths of hospitalization relate to the need for 
rehospitalization, one indicator of unfavorable outcome.  This dissertation describes the 
demographic and clinical features of patients who require multiple psychiatric hospitalizations 
for treatment of AN and identifies patient characteristics that predict both likelihood of and time 
to readmission in the current care environment.  Method: One-hundred-forty-seven patients with 
a primary diagnosis of AN and hospitalized on a specialized eating disorders psychiatric unit 
completed self-report questionnaires measuring eating disorders symptoms, mood, and 
personality functioning at admission and discharge. Medical record reviews yielded 
demographic, historical, and inpatient course of treatment information.  Medical records were 
later reviewed to determine which of the 147 patients had been readmitted to the same facility 
within 3 years of their index admission.  Multivariate logistic regression analysis was used to 
evaluate prediction of readmission status.  Cox regression survival techniques were used to 
evaluate prediction of time to readmission.  Parallel analyses were conducted on the full sample 
(n = 147) and on a subsample of patients (n=107) who were not discharged against medical 
advice (i.e., received an adequate dose of treatment).  Results:  Twenty-seven percent of the full 
sample and 31% of the subsample were readmitted within 3 years of their discharge.  Body 
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dissatisfaction and mood disorder diagnosis at discharge best predicted the likelihood of both 
readmission and time to readmission for the group of patients who received an adequate dose of 
inpatient treatment.  Discussion: The observed predictors differ from those typically associated 
with readmission in patients with AN.  The findings highlight the centrality of 
psychopathological aspects of AN and comorbid mood disorder, and they suggest a need to 
refine inpatient treatment interventions to more specifically target the psychological distress 
associated with body image disturbances and mood disorder. More broadly, the findings suggest 
the need to further evaluate the extent to which the managed care treatment environment is 
affecting treatment outcomes.  
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1.0  INTRODUCTION 
Changes in our health care system have had profound effects on the delivery of mental health 
care services.  Managed care practices have been implemented on a widespread basis across 
diagnostic groups and treatment settings with the stated intent of improving efficiency and 
reducing health care costs without loss of effectiveness (Bobbitt, Marques & Trout, 1998). 
Managed mental health care has significantly influenced access to care, as well as setting and 
duration of care for the privately and publicly insured.   Managed care penetration in mental 
health has seen explosive growth, and it is estimated that greater than 3 out of 4 individuals are 
enrolled in some form of a managed mental health plan (Sturm, 1997).  Managed mental health 
care has emerged as the dominant influence in the delivery of services to people with mental 
illness, having profound effects on patients1 as well as treatment providers.  In particular, 
treatment services for serious and potentially chronic mental disorders, like some eating 
disorders, have been the most affected (Weissman, Pettigrew, Sotsky, & Reigier, 2000; 
Williamson, Thaw & Vernando-Sullivan, 2001; Wiseman, Sunday, Klapper, Harris & Halmi, 
2000).  Providers too, have been affected.  One effect has been that as managed care policies 
have proliferated, social workers have increasingly become the providers of mental health 
                                                 
1 The author recognizes that use of the term “patient” rather than terms such as “consumer” or “client” may be 
considered inconsistent with Recovery Movement language.  The decision for use of the term “patient” was based 
primarily on the fact that the subjects being described in this study are people who are hospitalized on an inpatient 
unit and thus the term “patient” seemed the most precise and accurate descriptor.     
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treatment in the United States, by some estimates surpassing that which is provided by 
psychologists and psychiatrists (Cohen, 2003).  Clinical social workers provide as much as 65% 
of all psychotherapy and mental health services in the United States (Gibelman & Schervish, 
1997).  According to an Open Minds analysis cited in the NASW News, under managed care 
plans, social workers and other licensed professionals provide outpatient mental health care 56 
percent of the time, while psychologists and psychiatrist provide care only 33 and 11 percent of 
the time, respectively (O’Neill, 1999).  Moreover, a 1996 survey by the American Association 
for Marriage and Family Therapy documented the composition of 15 managed mental health 
care clinician panels and found that social workers dominated.  Eight of the managed care 
organizations reported that social workers comprised 30 percent or more of their panel.  Of those 
eight companies, two reported that their networks were 50 and 70 percent Master’s prepared 
social workers (American Psychiatric Association (APA), 1997). 
Studies examining outcome, specifically readmissions, for people with serious and 
chronic mental illness in the current care environment are emerging in the literature (Wickizer & 
Lessler, 1998); however, the empirical database is quite limited.   Identifying, defining, and 
measuring potential harm that occurs as a result of the use of managed mental health care 
techniques on various populations has been identified as an area in need of further examination 
(Mauery, Vaquerano, Sethi, Jee, & Chimento, 2006).  The current study examines one such 
population, individuals hospitalized with anorexia nervosa, and identifies predictors of 
readmission, one indicator of long-term outcome for anorexia nervosa patients. Reevaluating 
outcome and predictors of outcome in the current care environment is critically important 
because previous knowledge may not generalize to the current environment in which access to 
and duration of care are limited. 
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Anorexia nervosa (AN) is a serious mental illness that disproportionately affects young 
adult and adolescent females.  Although once considered to affect primarily upper middle class 
Caucasian females, it is now recognized as affecting individuals from all cultures and 
socioeconomic classes (Crago, Shisslak, & Estes, 1996).  AN affects about 0.5% of young 
females (Hoek, 2002) and affects females at a rate 9 times that of males (American Psychiatric 
Association (APA), 1994).  Although AN is not common, its consequences can be devastating to 
individual sufferers and their families.  AN is a difficult disorder to treat and is associated with 
significant psychiatric and medical  
comorbidity, high relapse rates, and mortality (Mitchell, Pomeroy & Adson, 1997).  AN has the 
highest known mortality rate of all psychiatric illnesses (Sullivan, 1995), with 5% of patients 
with AN eventually succumbing to the disorder (Steinhausen, 2002).   
Treatment for AN is protracted and expensive.  A typical course of treatment for AN is 
measured in terms of years and is marked by the need for medical and psychiatric intervention, 
on both an inpatient and outpatient basis (Strober, Freeman & Morrell, 1997).  The standards of 
care for severe AN specify extended hospitalization, prolonged outpatient mental health care and 
ongoing medical management (APA Practice Guidelines, 2006).  These standards of care conflict 
with the realities of providing treatment in a managed care environment.  Managed care policies 
dictate access to and type of care received, and they affect when, where, for how long, and by 
whom the patient will be treated.  The necessity to negotiate treatment decisions in the context of 
managed care may delay or curtail intensive (high cost) treatment.  For people with AN, the 
delay or curtailment may be associated with continued weight loss and increased morbidity 
resulting in more compromised individuals eventually being admitted for inpatient care, but for 
shorter lengths of stay that are inadequate to achieve symptom remission.  
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The consensus of expert opinion and research evidence demonstrates that restoration of 
adequate body weight is an essential first step in the treatment of AN. Due to the ego-syntonic 
nature of AN and the physiological factors associated with refeeding, inpatient treatment on a 
specialty care unit is often required to achieve weight gain.  The weight gain process is slow and 
thus necessitates longer lengths of stay than are customary in the current care environment.  
Premature discharge, i.e., discharge prior to achieving a minimally adequate body weight, is 
associated with worse short- and long-term outcomes, as detailed in the literature review below.  
Frequent but shorter admissions that are not sufficient to achieve adequate weight gain or 
symptom remission may, for some patients with AN, set the stage for multiple hospitalizations 
and increase the risk for the development of a chronic course of illness.             
1.1 IMPLICATIONS 
This study’s focus, identifying predictors of readmission for patients with AN in the current care 
environment, has implications for social work policy, practice, and service delivery.  
Readmissions are costly to patients, their families, and the mental health care system.  For 
patients and their families, there are substantial, and perhaps incalculable, physical, emotional 
and financial costs associated with numerous hospitalizations for AN.  Readmissions also burden 
already limited treatment resources and add additional expense to the overall system.  It is 
therefore incumbent upon social workers in policy making roles to understand the implications 
of our current method of service delivery and to advocate for policies that balance the needs of 
patients with AN with the very real cost and quality concerns that have traditionally plagued our 
mental health care system.   
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Moreover, it is critically important that policies influencing mental health care service, 
delivery, and financing are informed by empirical evidence.  Managed care has fundamentally 
altered the delivery of mental health services to patients with severe mental illness.  Difficulties 
accessing intensive and specialty care as well as abbreviated lengths of stay in intensive levels of 
care are complaints related to managed care that are often voiced by patients and practitioners, 
and that may affect outcome.  At present little is known about the outcomes of patients with 
severe mental illness who receive treatment in the current care environment of restricted access 
and limited duration of inpatient stay.  Studies describing the short-term outcome of patients with 
AN in the current care environment are emerging (Treat, Gaskill, McCabe, Ghinassi, Luczak, & 
Marcus, 2005; Treat, McCabe, Gaskill, Bardone-Cone, & Marcus, under review).  The current 
study will add to this knowledge base by examining predictors of readmission, one important 
indicator of the long-term treatment outcomes of severely ill patients with AN.  In addition to 
enhancing our understanding of and informing treatment protocols for patients with AN, the 
findings also may shed light on concerns related to the outcomes of patients diagnosed with other 
severe mental illnesses that have been affected by managed care policies that limit access and 
duration of care.  The findings therefore can help to inform and drive public policy related to 
mental health care delivery and financing for all patients diagnosed with severe mental illnesses. 
The study’s findings may have important implications for those treating patients with 
AN, many of whom, as noted, are social workers.  The ability to identify predictors of 
readmission in patients with AN prospectively will inform the design of clinical interventions 
aimed at reducing readmissions.  As providers of mental health treatment, social workers must 
have at their disposal empirical evidence to inform patient care decisions and recommendations.  
Effectively treating patients with AN with fewer admissions will diminish the consequent 
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personal costs associated with a chronic course of AN and reduce overall costs to the mental 
health care system. 
Finally, the study may have implications for mental health services delivery.  The effect 
of practices that limit access and duration of care on the treatment outcomes of people with 
severe mental illnesses has not been fully examined.  The descriptions of patients with AN and 
their outcomes will inform the development of standards of care that take into account the 
implications of treating patients with serious mental illnesses in a managed care environment, 
information that is currently absent in the literature.  Thus, the study’s findings should help 
inform the design of more effective systems of care. 
 
1.2 PRESENT STUDY 
The overarching aims of this study are to describe the demographic and clinical features of 
patients who require multiple psychiatric inpatient hospitalizations for the treatment of AN and 
to identify patient characteristics that predict readmission.  In light of the changes in the mental 
health care delivery system that have occurred over the last 15 years, it is critically important to 
re-examine both short and long-term outcomes of inpatient treatment for AN, because predictors 
of readmission based on prior research may not generalize to the current care environment.   This 
study is significant because its sample is drawn from an eating disorders specialty program that 
treats relatively large numbers of patients with AN who are seriously ill.  Samples of this size are 
difficult to obtain due to the disorder’s low prevalence rate and the difficulties associated with 
recruiting patients who are resistant to efforts to engage them in treatment.  Thus, this study 
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provides an opportunity to examine with sufficient power the characteristics of patients 
readmitted for treatment of AN who are treated in a managed care environment in which access 
to intensive treatment and length of stay has been restricted.   
Data for this study were collected as part of a clinical pathways project designed to 
develop a best practice description of inpatient eating disorders treatment (Treat, Gaskill, 
McCabe, Ghinassi, Luczak & Marcus, 2005).  Data were collected from 147 patients with AN 
who were consecutively admitted to the eating disorders unit of a psychiatric hospital over a 22-
month period of time.  Demographic information, patient self-report questionnaires and 
information obtained from review of the medical record are included in the analysis.  Patient 
self-report questionnaires were used to assess eating disorder and depressive symptoms, as well 
as difficulties in interpersonal functioning, at admission to and discharge from inpatient 
psychiatric treatment.  Information obtained through medical record review includes all weight 
related information, Axis I diagnoses, and historical information, such as number of prior eating 
disorders, psychiatric hospitalizations, and duration of illness.   
The analysis will consist of a detailed description of both the full sample (n =147) and the 
subsample of patients who were readmitted to the inpatient eating disorders unit within 3 years 
of discharge (n = 40).  A parallel set of analyses will be conducted on a subsample of patients (n 
= 107) who were not discharged against medical advice and thus received an adequate dose of 
treatment.  This subsample of patients is arguably more representative of those who have 
received an adequate dose of treatment in the current care environment and are thus a better 
group from which to identify predictors of readmission.  Tables will present univariate 
descriptive statistics for the full sample and the subsample at admission (e.g., means and 
standard deviations for continuous variables, frequencies and percentages for discrete variables).  
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Potential predictors that will be examined include age, number of prior eating disorders 
psychiatric admissions, duration of illness, and percent of ideal body weight at admission to and 
discharge from inpatient treatment.  Additionally, psychiatric symptoms, including eating 
disorder and depressive symptoms, difficulties in interpersonal functioning, and presence of 
additional Axis I diagnoses at discharge, will be examined as potential predictors of readmission.  
Table 2 presents a full list of all examined predictors.  Axis I diagnoses at admission will not be 
examined because the patient’s low weight status at admission compromises the validity of 
assessment of other Axis I diagnoses (i.e., many ostensibly comorbid conditions resolve with 
weight gain).  Similarly, we will not examine GAF scores at admission or discharge because they 
are notoriously unreliable. Medications at admission also will not be evaluated because of the 
difficulties in interpretation associated with the widely varying prescribing practices of the 
numerous physicians who were treating the patients prior to admission.  Significant predictors 
that emerge in preliminary bivariate analyses then will be examined in multivariate logistic-
regression and survival analyses.   All continuous-variable distributions will be inspected for 
normality and transformed as necessary prior to inclusion in the multivariate parametric 
analyses. 
The empirical knowledge base from which to draw information about predictors of 
relapse and readmission in AN is quite limited (Carter, Blackmore, Sutandar-Pinnock , & 
Woodside, 2004).  Further complicating the identification of applicable predictors is the fact that 
much of the work in this area was conducted prior to the widespread implementation of managed 
care; therefore, the findings may not translate well to the current care environment.  Moreover, 
much of the work in this area examines predictors of relapse, rather than readmission.  Inherent 
in the definition of AN relapse is the notion that a period of remission from the illness (i.e., 
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weight restoration) was achieved.  As patients now commonly are discharged from inpatient 
units prior to full weight restoration, remission may not be attained prior to readmission.  
Nonetheless, the factors that are associated with relapse are relevant to our understanding of 
predictors of readmission and are therefore considered here.   
Body weight at both admission to and discharge from inpatient treatment has been well 
established as a predictor of outcome, including relapse and readmission (Baran, Weltzin, & 
Kaye, 1995;  Fichter & Quadflieg, 1999; Heberbrand et al., 1996; Commeford, Licinio, & Halmi, 
1997; Heberbrand et al., 1997; Lowe, et al., 2001; Pike, 1998; Steinhausen, Grigoroui-
Serbanescu, Boyadjieva, Nuemarker, & Metzke, 2008; Treat et al., under review; Zipfel, Lowe, 
Reas, Deter, & Herzog, 2000).  Duration of illness (Deter & Herzog, 1994; Fichter & Quadflieg, 
1999; Richard, Bauer, & Kordy, 2005) and delay in treatment initiation (Steinhausen, 1995; 
Zipfel, Lowe, Reas, Deter, & Herzog, 2000) have also been found to have predictive value.  
Willer, Thuras, & Crow (2005) found increased length of stay, more rapid rate of weight gain, 
and having prior hospitalizations increased the likelihood of re-hospitalization.   Their somewhat 
unexpected finding that increased length of stay was associated with re-hospitalization was 
explained in further analyses demonstrating that increased length of stay was correlated with 
more prior hospitalizations and lower body mass index at admission.   Similarly, previous AN 
treatment has been identified as a predictor of relapse by Carter, Blackmore, Suandar-Pinnock 
and Woodside (2004). Purging behavior has also been associated with relapse (Fichter & 
Quadflieg, 1999; Garner, & Rosen, 1993; Deter & Herzog, 1994; Eckert, Halmi, Marchi, Grove, 
& Crosby, 1995 Herzog & Schellberg & Deter, 1997).  In a smaller number of studies, greater 
severity of social and psychological problems have been identified as predictors of poor outcome 
(Carter, Blackmore, Suander-Pinnock, & Woodside, 2004; Herzog, Schellberg & Deter, 1997; 
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Lowe, Zipfel, Buchholz, Dupont, Reas,& Herzog,  2001).  In sum, the most frequently reported 
predictors of relapse and readmission among patients with AN are weight, duration of illness, 
and purging sub-type of AN.    
On the basis of this literature, we hypothesize that more previous admissions, longer 
duration of illness, greater psychiatric symptomatology, and lower percent of ideal body weight 
at admission and discharge will predict readmission and time to readmission, as these variables 
represent indicators of greater severity of illness.  The previous admissions and duration of 
illness variables are indicators of whether or not the illness is refractory to treatment.   These 
variables may also be an indication that the duration of previous inpatient treatment was not 
sufficient to achieve restoration of normal body weight, thus leading to increased risk for 
multiple hospitalizations.  The psychiatric symptomatology variable is a measure of the degree of 
psychiatric distress.  Greater psychiatric symptomatology would be an indicator of more 
complicated and difficult-to-treat illness and thus is hypothesized to contribute to readmissions.  
Both clinical opinion and empirical evidence indicate that lower percent of ideal body weight at 
admission and discharge is associated with more negative short- and long-term treatment 
outcomes.  Thus, it is hypothesized in this study that lower percent of ideal body weight at 
admission and discharge will predict readmissions.  Further explication of the relevance of these 
variables to the likelihood of readmission is described in the literature review below.   
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2.0  LITERATURE REVIEW 
The theoretical foundation for the current study draws on two separate but related literatures.  
The managed care literature describes the evolution of a system of care delivery that attempts to 
integrate the frequently competing demands of improved access to and quality of care and cost 
containment.  The effect of managed care on the treatment of serious mental illness has not been 
fully examined.  This study examines one important aspect of outcome, readmission, for one 
serious mental illness, AN, in the context of managed care policies that restrict access to and 
duration of care.  This literature review will chronicle the emergence of managed care and 
describe its impact on the delivery of mental health services to patients with serious mental 
illness. The review of the AN literature will summarize our current understanding of a 
psychiatric illness that was first described in the medical literature of the 17th century and today 
remains poorly understood in terms of etiology and effective treatments.  The review will 
illustrate the incompatibility of the current system of mental health care delivery and the 
established treatment guidelines for AN.  Finally, the review will present the previous research 
that led to the specific hypotheses about predictors of readmission.  
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2.1 MANAGED CARE 
We are currently in an era of unprecedented change in the health care industry, referred to by 
some as the “managed care era”.  It is an era in which the research advances of previous decades 
have yielded new understandings of and technologies for ameliorating disease and human 
suffering.  It is also an era in which spiraling health care costs, largely related to these 
technologies, have generated a demand for health care reform, and more specifically cost 
containment.  The existence and availability of these technologies have spurred debate and 
controversy and have called into question societal values: is health care a basic entitlement for all 
citizens or is it a privilege for those who can afford to pay?  Basic health care is unavailable to 
large numbers of Americans.  Estimates based on data collected from the 2007 National Health 
Survey Interview indicate that 42.5 million Americans of all ages were uninsured at the time of 
the interview and 53.2 million had been uninsured for at least part of the year prior to the 
interview (Cohen & Martinez, 2007).  Talbott (2001) reported that at any given time between 30 
and 40% of the United States population is without heath insurance coverage.  Moreover, the 
United States rates far below other industrialized nations in most public health indices.  
Comparisons to other industrialized nations reveal a system that ranks poorly in terms of ability 
to organize, deliver, and finance health care.  Although the American system is criticized as 
being inefficient, unfair, and expensive, it is the high and uncontrolled cost of our system that 
has motivated reform efforts.  Unfortunately, the legislative and policy reform efforts, described 
below, have done little to address the other valid criticisms and may have exacerbated the 
inefficiency and inequity problems.. 
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2.1.1 Defining Managed Care 
In response to the call for reform, private sector and public policy changes, in the form of 
managed care practices, have been implemented to reduce the financial cost of health care.  
Sturm (1997) estimated that three out of four individuals are enrolled in some form of managed 
medical care.  Managed care penetration in mental health is estimated to be even higher (Sturm, 
1997).  Managed care is a complex concept with multiple and varying definitions.  Talbott 
(2001) described managed care as consisting of four inter-related elements.  First, managed care 
is a method of providing care that makes use of specified provider groups, networks or carve-
outs.  Second, it is a philosophy of care that emphasizes health maintenance, 
prevention/limitation of hospitalization and alternatives to hospitalization.  Third, managed care 
is method for financing care.  Finally, managed care controls costs by covering only specific 
diagnoses, utilizing guidelines for treatment, and by reviewing the proposed and ongoing care to 
determine medical necessity.    
Mechanic (1999) described four basic mechanisms that are central to the concept of 
managed care.  These mechanisms are capitation, incentives and risks, gatekeeping and 
utilization management. Since these mechanisms are critical to our understanding of how 
managed care affects treatment delivery, the following definitions are provided. 
Capitation is the practice of prepaying a treatment provider a fixed, predetermined 
amount per person covered, for specified services over a specified period of time.  Theoretically, 
this type of payment promotes the efficient use of resources.  In practical terms, however, the 
likelihood exists for promoting the use of the least expensive treatments (i.e., outpatient care), 
not necessarily the most appropriate.  Under capitation, the use of too many expensive services 
(i.e., inpatient care) would result in financial losses while the use of less expensive services 
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would result in higher earnings or cost savings.  Conversely, in a fee-for-service system, 
providers are financially rewarded for providing the most expensive, not necessarily the most 
effective or appropriate care.  Both systems have inducements that may serve to limit a patient’s 
access to appropriate, cost effective treatment. 
Incentives and risks in managed mental health care refer to the practice of paying bonuses 
or withholding earnings to limit referrals to specialists. Incentives and risks typically apply to 
primary care physicians (PCPs), who, by virtue of their gatekeeping role, are in a position to 
refer patients to mental health specialists.  Essentially, PCPs may have part of their income 
withheld for exceeding a predetermined threshold of referrals for specialty care or they may 
receive a bonus for keeping referrals within an expected target.  Mental health practitioners 
typically work under a reduced payment fee-for-service arrangement.  Their treatment decisions 
are then managed through various utilization management techniques further described below.   
Gatekeeping is the process of requiring referrals for specialty care.  The objective of 
gatekeeping is to limit access to specialists, hospitals, and expensive procedures.  As noted 
above, gatekeeping is most typically the role of the PCP.  In many managed care plans, all 
referrals for specialty care must go through the PCP.  Specialty care that is directly accessed by 
the patient is not paid for by the plan.  Overt gatekeeping by PCPs has been eliminated in some 
plans, although the objective of limiting access to specialty care remains intact through the use of 
utilization management techniques such as precertification, which is described below. 
Utilization management is a broad term that refers to a number of practices: 
precertification, concurrent review, high cost case management and second opinion programs.  
Most relevant to this review are the concepts of precertification and concurrent review.  
Precertification refers to the practice of requiring that the patient and or mental health 
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practitioner obtain authorization from the managed care company prior to receiving any inpatient 
or outpatient services.  To obtain authorization, a description of the patient’s presenting problems 
is required.  The utilization reviewer, typically a nurse or master’s prepared clinician, bases the 
decision to authorize treatment on clinical judgment or an algorithm developed by the managed 
care company.  The soundness of the decision therefore, is based on the quality of the criteria 
used and the experience and clinical judgment of the reviewer.  There is usually opportunity to 
appeal decisions.  Utilization review practices vary widely across managed care companies, and 
the quality or appropriateness of decisions rendered is highly dependent upon the managed care 
company.     
Concurrent review is the process of requiring clinicians to report, either verbally or in 
writing, the progress made, remaining symptoms (frequency and severity), short and long term 
goals, mental status exam, and rationale for continuing treatment in order to obtain continued 
authorization for treatment.  Concurrent review is a mechanism designed to encourage the use of 
alternative levels of care and thereby reduce length of stay in intensive, high cost levels of care.  
It is also used to monitor the course of treatment.  Concurrent review is labor intensive and costly 
in terms of clinician time and administrative overhead to mental health providers and managed 
care companies.  
2.2 SOCIAL POLICY BACKGROUND 
As illustrated by the previous description of managed care mechanisms, considerable 
administrative and clinical effort is required to function in a managed care environment.  Clearly, 
the administrative and clinical overhead adds significant expense to the cost of providing and 
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financing care.  This would appear to contradict the goals of managed care, which are to reform 
the mental health care delivery system by reducing costs and increasing efficiency.  However, 
the issue of health care reform is a complex subject, not easily evaluated and confounded by 
competing political, social and economic agendas.  A brief review of the legislation that set the 
stage for the emergence of managed care illustrates the interplay of these agendas and the 
difficulty associated with assessing and measuring reform efforts.  
Beginning in the late 1970s and continuing through the 1980s, the federal government 
passed landmark legislation that greatly changed the financing and delivery of health benefits, 
including mental health services.  The Health Maintenance Organization (HMO) Act of 1973 and 
the Employee Retirement Income Security Act (ERISA) of 1974 established the groundwork for 
today’s managed care dominated health care scene.  The intent of the HMO Act of 1973 was to 
reduce employer health costs by permitting health care practitioners to organize HMOs to 
compete with health insurance plans (Oss & Mackie, 1995).  It is significant to note that this Act 
allowed profit-making corporations to enter what had essentially been a non-profit, consumer-
driven prepaid group practice arena.  This law is credited with changing the direction of the 
private health care delivery system to one based on what has become known as managed care.  
ERISA was intended to encourage employers to self-insure health benefits, essentially giving 
them the ability to create their own employer managed health benefit plan (Sipkoff & Oss, 
1995).   
Both ERISA and the HMO Act had a significant impact on the mental health field.  
According to the American Psychiatric Association (APA), “the HMO Act essentially 
institutionalized a minimum level of mental health benefits by failing to require the same level of 
comprehensive coverage for psychiatric care as it did for all other physical illnesses and health 
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care services”(APA, 1997).  As federal legislation, ERISA further diminished insurance 
coverage for mental health services and increased the disparities between physical health and 
mental health benefits by exempting employer-sponsored health plans from the minimum benefit 
requirements and mental health parity regulations passed by state legislatures.  The APA 
contends that as more employer-sponsored health plans have limited or eliminated mental health 
care benefits from their plans, the cost of providing care to the uninsured has been shifted to the 
public mental health system, where it has steadily increased.  
In response to growing concerns regarding access to care, the Mental Health Parity Act 
was passed in 1996 and implemented in 1998.  This act required that annual and lifetime dollar 
limits for mental health care be eliminated or be equal to other physical illnesses for all United 
States group health care plans that offer mental health benefits and serve more than 50 
employees. The act overrode exclusions in ERISA that had exempted at least one third of the 
population covered by self-insured employers from state-level parity legislation (Varmus, 1998).  
This was an important step toward parity in all states, although the act did not address other 
managed care practices that can affect access to care.  For example, day and visit limits, higher 
co-pays and deductibles, and aggressive utilization review may still be applied to those with 
mental illness, thus effectively limiting their access to care.  Moreover, the act applied only to 
mental illnesses as defined under individual plans, and plans are not required to provide mental 
health coverage.  Consequently, it is doubtful that parity legislation alone, as currently defined 
will be sufficient to assure access to mental health services in the presence of managed care.    
Managed care has similarly influenced the public sector by penetrating systems that have 
traditionally been privately administered, such as child welfare, mental retardation, corrections, 
and residential care (O’Neill, 1999) and Medicare and Medicaid programs. Increasingly, states 
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are looking to managed care as a means of controlling mental health costs and quality for its 
Medicaid populations. For example, the Commonwealth of Pennsylvania began shifting its 
Medicaid populations from fee-for-service plans to capitated, mandatory managed plans for both 
physical and mental health benefits with the introduction of HealthChoices in February of 1997.  
Enrollment began with five counties in the southeastern part of the state, which included 
Philadelphia County and the four surrounding counties.  Since that time, major expansions 
occurred in 1999 and 2002 and have included 20 counties in southwestern and south central 
Pennsylvania bringing the total enrollment to over 900,000 Medical Assistance consumers. Plans 
are currently underway to enroll the northwestern part of the state. It is anticipated that by the 
end of 2007, all Pennsylvania counties will be enrolled in a mandatory managed care plan for 
mental health services (http://www.dpw.state.pa.us.behavementalhealth). 
2.3 IMPACT OF MANAGED CARE 
Although it is generally recognized that managed care practices result in some reduction of 
health care spending (Varmus, 1998), the practices raise serious concerns from patients, 
providers, and policy-makers regarding access to care and quality of care received.  Managed 
care practices such as capitation, incentives and risks, gatekeeping, and utilization management, 
that are intended to achieve cost savings may not be (e.g., Abelson, 1999; Freudenheim, 1998).  
Moreover, these practices may in fact be exacting an unacceptable toll on public health and 
welfare.  Evaluations of managed care’s effect on delivery of services to persons with serious 
mental illness in the public sector have been largely negative.  The National Alliance for the 
Mentally Ill (NAMI) has been an active observer of the effects of managed care on mental health 
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services and in 1997 issued the Managed Care Report Card.  The report concluded that the 
industry “fails on the basic elements of care that people with serious brain disorders need to 
survive” (Hall, Edgar, & Flynn, 1997).  Similarly, Ross (2000) concluded that managed care has 
failed to deliver on its promise of improving delivery of services to persons with serious mental 
illness.  Specifically, he cited the absence of integration of Medicaid and the public mental health 
system, a general lack of publicly documented performance measurements that demonstrate 
accountability, and the absence of meaningful and authentic consumer, family, and enrollee 
participation in service planning, implementation, and evaluation as flaws that have hindered the 
adequate provision of services.   
Research examining the impact of managed care on access to and quality of mental health 
services is limited.  Weissman et al. (2000) examined the impact of managed care on access to 
mental health services by comparing pre-managed care data reported in the Epidemiologic 
Catchment Area study (early 1980s) and the National Comorbidity Survey (early 1990s) which 
described the use of mental health services by adults in public and private settings with published 
data from managed care programs reporting cost and access data for the time period 1992-1997.  
Their findings raise concerns that plans paying lower per-member, per-month costs actively 
contain costs by restricting access to specialty treatment.  The authors concluded that benefit 
designs that include cost containment strategies such as high co-payments and deductibles, 
stringent authorization of care practices, and incentives to reduce referrals to specialty treatment 
effectively limit access to mental health care.    
The managed care practice of utilization management has been associated with increased 
likelihood of psychiatric readmission, thus raising quality of care concerns as well as calling into 
question claims of cost reduction and containment. Wickizer and Lessler (1998) found that 
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psychiatric patients for whom length of stay was restricted by utilization management were more 
likely to be readmitted, and they concluded that utilization management restricted access to 
inpatient psychiatric care by limiting length of stay.  
Practices that limit access to and duration of care have particularly worrisome treatment 
and outcome implications for serious mental illnesses such as AN.  Treatment for low-weight 
AN has traditionally required extended hospitalization to achieve medical stabilization, weight 
restoration, and promotion of psychological recovery.  Thus, AN is one of the mental illnesses 
most affected by managed care practices (Williamson, et al., 2000).   
Treatment for AN is often protracted and expensive and, as such, is at odds with managed 
care practices that emphasize restricted access to intensive treatment and limit duration of care. 
Kaye, Kaplan, & Zucker, (1996) have observed that restricted access to care and limitations on 
duration of care for patients with AN may be creating what they refer to as a “revolving door 
effect.”  That is, patients do not initially receive adequate treatment to achieve symptom 
remission.  This, in turn, places them at high risk for relapse and ultimately results in more 
severe illness requiring frequent, albeit short admissions. Vandereyken (2003) concurred with 
this observation and contended that the economic restraints imposed by managed care drive this 
revolving door and result in increased costs. These findings and observations are significant 
given the pressures to restrict access to and duration of intensive levels of care even though such 
care typically is required to safely restore weight in patients with AN who are low weight, and 
they call into question the quality and adequacy of care provided in such an environment.  
Moreover, they clearly challenge the efficacy of limiting access to care as a cost-savings 
mechanism, as they may be associated with greater financial and human costs.    
 20 
Concerns about the potential effect of managed care practices on treatment for AN are 
well documented in the literature (Franko & Erb, 1998; Kaye, Enright, & Lesser, 1988; Kaye, 
Kaplan, & Zucker, 1996; Silber & Robb, 2002).  However, there is limited research 
demonstrating the impact of managed care on AN treatment outcome. The following review of 
the literature describing anorexia nervosa and its treatment will illustrate the inherent difficulties 
associated with treating this disorder in the current care environment. 
2.4 ANOREXIA NERVOSA 
2.4.1 Diagnostic Criteria 
AN is a perplexing and debilitating illness that affects both the mind and body.  It remains poorly 
understood in terms of etiology, and little is known regarding effective treatments. The APA 
(1994) diagnostic criteria for AN include physical and psychological criteria.   AN is physically 
characterized by low body weight, refusal to gain or maintain normal body weight, and loss of 
menses in postmenarcheal females.  Psychological characteristics of AN include intense fear of 
weight gain or becoming fat even though underweight, disturbance in the way in which one’s 
body weight or shape is experienced, undue influence of body weight or shape on self-
evaluation, or denial of the seriousness of the current low body weight.  The APA definition of 
AN is further specified by two subtypes: restricting type and binge-eating/purging type.  These 
subtypes refer to the presence or absence of binge eating and purge behaviors that are intended to 
rid the body of calories, i.e., self-induced vomiting, or the misuse of laxatives, diuretics or 
enemas.  
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2.4.2 Prevalence 
AN affects approximately 0.5% of young females (Hoek, 2002; Wilson & Pike, 2001) from all 
cultures and socioeconomic classes (Crago, Shisslak, & Estes, 1996).   There is some evidence to 
suggest that the incidence of AN is increasing, however the data are conflicting; some data 
suggest that the rate is increasing (Eagles, Johnston, Hunter et al., 1995; Lucas, Beard, O’Fallon 
et al.., 1988; Milos, Spindler, Schnyder et al., 2004) while other data suggest a stable rate (Hall 
& Hay, 1991; Hoek, Bartelds, Bosveld et al., 1995).  The peak age of onset is between 15 and 19 
years of age (Lucas, Beard, O’Fallon, et al., 1991), although there are reports of prepubertal 
(Gowers, Crisp, Joughin et al., 1991) and mid- and late-life onset presentations (Beck, Casper, & 
Andersen, 1996; Inagaki, Horiguchi, Tsubouchi et al., 2002).  Although onset of AN typically 
occurs in late adolescence, the need for treatment extends well into adulthood (Streigel-Moore, 
Leslie, Petrill, Garvin, & Rosenheck, 2000).   
2.4.3 Course 
Studies examining the course and outcome of AN document that it is an illness that can be highly 
refractory to known treatments and often requires long term and intensive intervention.  
Moreover, AN is characterized by unacceptably high relapse and mortality rates.  Pike (1998) in 
her review of the literature reported relapse rates of 30-50%.  Steinhausen’s review of AN 
outcome in the 20th century reports that full recovery is achieved in only about 47% of patients.  
Approximately one-third of patients with AN improve, living with only partial or residual 
features of the disorder, and 20% remain chronically ill over the long term (Steinhausen, 2002).  
Death occurs in approximately 5% of patients with AN (Steinhausen, 2002), a rate higher than 
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that of any other psychiatric illness (Sullivan, 1995).  About half of the deaths in patients with 
AN occur as a result of suicide.  The remainder are a result of cardiac abnormalities, organ 
failure, or other physical complications of AN.  Strober, Freeman, & Morrell, (1997) followed 
adolescents who were hospitalized for AN for a 12-15 year period post hospitalization.  They 
describe a typical course of treatment as being 60-72 months. 
2.4.4 Etiology 
The etiology of AN is not known.  Available evidence documents that it is multi-determined, 
resulting from a complex interplay of biological, genetic, psychological, familial, and 
environmental/cultural factors (APA, 2006).  The extent to which any one of these factors 
influences the development of the disorder is a subject of ongoing inquiry.   
Families, and in particular their patterns of interaction, have long been implicated in the 
onset and maintenance of AN (e.g., Bruch, 1973; Gull, 1874; Minuchin, Rosman, & Baker, 
1978; Selvini Paazzoli, 1974).  Constructs such as enmeshment, over-protectiveness, rigidity, 
and lack of conflict resolution have been associated with families of patients with AN and have 
been theorized to at least maintain, if not cause, AN.   Likewise, sociocultural factors, 
specifically the idealization of thinness as a symbol of beauty, have also been implicated as 
factors in the development of AN (Anderson-Fye & Becker, 2004).  Although these explanations 
have considerable face validity, there is no empirical evidence to support the claim that families 
or sociocultural factors cause AN.  Cultural influences that idealize thinness are pervasive in 
Westernized cultures and may contribute to or moderate risk for the development of an eating 
disorder in vulnerable individuals. However, the influence of culture alone is now recognized as 
being insufficient to cause AN.  Similarly, problematic styles of interaction and communication 
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may be present in families of patients with AN, and may need to be a focus of therapeutic 
efforts; however, it is unlikely that the presence of specific styles of family interactions alone is 
sufficient to cause AN.   
Research focused on the role of biological and genetic factors in the development of AN 
has yielded interesting results that challenge previously held conceptualizations of AN.  There is 
now a growing body of research that has found significantly greater lifetime prevalence of eating 
disorders, including AN, among relatives of people with eating disorders compared to relatives 
of controls, suggesting that biology plays a substantial role in the etiology of AN (e.g., Lilenfeld, 
et al., 1998; Strober, Freeman, Lampert, Diamond, & Kaye, 2000; Strober, Lampert, Morrell, 
Burroughs, & Jacobs, 1990).  These studies controlled for the effect of shared environment and 
demonstrated that genetic factors account for the expression of AN in families.  
Individual biologically based personality factors have also been examined as potential 
contributors to the development of AN.  In a study done by Bulik, Sullivan, Tozzi, Furberg, 
Lichtenstein, and Pedersen (2006), neuroticism, defined as emotional instability, low self-
esteem, and feelings of anxiety, depression, and guilt, emerged as a significant prospective 
predictor of AN.  This finding suggests that early existence of neuroticism may predispose 
individuals to AN.  Findings from Anderluh, Tchanturia, Rabe-Hesketh, and Treasure (2003) 
suggest that childhood histories of obsessive-compulsive traits, specifically perfectionism, 
rigidity, and rule-bound behavior, may be associated with increased risk for developing AN.  
There is also evidence to suggest that high rates of childhood anxiety disorders, specifically 
generalized anxiety disorder and obsessive compulsive disorder, precede the development of AN 
(Bulik, Sullivan, Fear & Joyce, 1997). 
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2.4.5 Psychiatric Comorbidity 
Co-occurring psychiatric illness is common among patients with AN seeking treatment at 
tertiary-level psychiatric treatment centers (APA, 2006).  The presence of other psychiatric 
illnesses adds complexity to diagnosis, treatment, and outcome and thus is included as a variable 
in our examination of predictors of readmission.  Steinhausen (2002) found in his review of 119 
studies of close to 5600 patients diagnosed with AN  that one-quarter of participants had anxiety 
disorders and one-quarter had affective disorders.  He also found that anxiety disorders and 
phobias, affective disorders, substance use disorders, obsessive compulsive disorder (OCD), and 
unspecified personality disorders, including borderline personality disorder, were very common 
diagnoses at follow-up.  Moreover, there was evidence that depression, anxiety disorder, 
phobias, and personality disorders served as risk factors contributing to less than favorable 
outcome in patients with AN.  
Other studies report similarly high or higher rates of co-occurring psychiatric illness.  
Two studies have found lifetime co-occurring major depression or dysthymia in 50-75% of 
patients with AN (Halmi et al., 1991; Herzog, Nussbaum & Marmor, 1996).   High rates of OCD 
and obsessive compulsive symptomatology are also well documented in the literature (Godart, 
Flament, Perdereau, Jeammet, 2002; Halmi et al., 1991; Kaye, et al., 2004), with OCD frequently 
predating the onset of AN (Anderluh, et al., 2003; Bulik, et al., 1997). Co-occurring anxiety 
disorders, particularly social phobias, are common among patients with AN (Herzog et al., 1992; 
Kaye et al., 2004).  Studies report an estimated 12-18% of patients with AN have co-occurring 
substance abuse.  These studies have further established that substance abuse is found primarily 
in those patients with the binge eating, purging subtype of AN (Bulik, et al., 2004; Halmi et al., 
1991; Herzog et al., 1992).  
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2.4.6 Medical Complications 
Serious medical complications are common in AN (Mitchell, Pomeroy & Adson, 1997). AN has 
a significant impact on physical health and often results in serious and chronic secondary health 
problems that are sometimes fatal.  Consequently, the physical health of patients with AN 
requires careful evaluation, ongoing monitoring, and intervention. Many of the medical 
complications associated with AN are a result of the effects of starvation.  Keys, Brozek, 
Henschel, Mickelsen and Taylor (1950) from the University of Minnesota demonstrated 
definitively that physical as well as emotional health is affected by starvation.  This study 
contributed significantly to our understanding of AN by demonstrating that symptoms once 
thought to be primary symptoms of AN were in fact attributable to starvation.  Many of the 
psychological, cognitive, and behavioral changes described in the Keys et al. study as being 
associated with starvation are commonly seen in AN.  Psychological changes associated with 
starvation and seen in AN include depression, anxiety, irritability, lability, social withdrawal and 
decreased self-esteem.  Cognitive changes precipitated by starvation and commonly seen in AN 
include decreased concentration, poor judgment and apathy.  The changes in behavior typically 
seen in AN such as food preoccupation, increased interest in cooking and recipes, unusual eating 
habits, overuse of condiments, spices, and caffeinated beverages are also associated with 
starvation.  Thus, diagnoses of comorbid conditions often are deferred until after refeeding has 
occurred. 
Common physical complications secondary to starvation and frequently seen in AN 
include cardiovascular abnormalities such as bradycardia and hypotension, electrolyte 
disturbances, endocrine abnormalities including amenorrhea, hematological irregularities, 
gastrointestinal problems, bone and metabolism abnormalities, neurological  abnormalities, and 
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skin and hair changes (Mitchell, Pomeroy & Adson, 1997).  Behaviors such as binge eating and 
vomiting, and the use of substances such as diet pills, diuretics, laxatives, and emetics, used to 
reduce weight, further increase the risk of medical complications.     
Most physical, psychological, cognitive, and behavioral effects of starvation normalize 
with nutrition rehabilitation and weight gain; however, some physical complications may not 
resolve following restoration of adequate nutrition and weight restoration.  Physical 
complications such as osteoporosis and infertility (Pike & Striegel-Moore, 1997), cerebral 
atrophy (Kingston, Szmuckler, Andrews, Tress, & Desmond, 1996) and growth retardation 
(Lantzouni, Frank, Golden, & Shenker, 2002) may not reverse with nutrition and weight 
restoration.  
2.4.7 Treatment 
Experts agree that AN requires intensive medical and psychological treatment (van Furth, 1998); 
however, there is a remarkably little research to guide decisions regarding AN treatment and 
treatment setting (e.g., Fairburn, 2005; Strober, 2005).  The paucity of AN treatment research is 
related to the difficulties associated with recruiting sufficient numbers of persons with a disorder 
that has a low prevalence rate who are often difficult to engage in treatment, and who require 
long-term treatment.  Consequently, few data exist on the long-term efficacy of treatment for 
patients with AN. 
Although there is not compelling evidence to guide our decision-making regarding 
treatment setting (hospital vs. ambulatory), psychosocial intervention, and medication use, 
evidence does exist to support the necessity of weight restoration as a necessary and primary 
component of treatment (APA, 2006) and a significant predictor of outcome (Zipfel, Lowe, Reas, 
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Deter, & Herzog, 2000).  As such, weight at admission and discharge will be examined as a 
predictor of readmission in the present study.  Support for the importance of weight as a 
predictor of outcome is provided by Baran, Weltzin and Kaye (1995), who found that more than 
50% of patients with AN who were discharged from inpatient hospitalization while still 
underweight reported significantly higher rates of re-hospitalization and endorsed more 
symptoms than those who achieved normal weight prior to discharge. Similar findings were 
reported by Commerford , Licinio and Halmi (1997) in their 5-year follow-up study of 31 
patients diagnosed with AN and bulimia nervosa.  They concluded that those patients who met 
all discharge criteria, including attainment of target weight at the time of discharge, had a 
significantly higher percent of ideal body weight and were less likely to have relapsed than those 
who did not meet the discharge criteria at follow-up.   Heberbrand et al.,(1996 and 1997) added 
further support for the significance of weight as a predictor of outcome with their findings that a 
lower weight at referral for treatment was associated with less frequently attained normal body 
weight and greater risk of chronic AN and death. Our own research, described at the end of this 
review, also documents a link between weight at either referral or discharge and short-term 
outcome (Treat et al., under review). There are no available data to indicate that brief inpatient 
stays are associated with good long-term outcome (APA, 2006).   
2.4.8 Treatment Setting 
The research findings described above support the importance of weight gain in the treatment of 
AN, but research addressing the optimal setting for weight restoration is sparse.  AN treatment 
occurs in a variety of settings, ranging from intensive eating disorder specific inpatient units to 
residential and partial hospitalization programs to outpatient programs of varying intensities.  In 
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general, patients who are very low weight (defined as less than 85% of an individually 
determined healthy weight) have considerable difficulty gaining weight without the support and 
structure of a specialized inpatient unit (APA, 2006).  Physical parameters to consider in 
determining treatment setting include weight, rate of weight loss, cardiac function and metabolic 
status (APA, 2006; LaVia et al., 1997).  Additional factors to consider in determining treatment 
setting include suicidality, motivation to recover, the presence of co-occurring disorders, the 
ability to control compulsive exercise and purging behavior, environmental stressors, and 
geographic availability of treatment program (LaVia et al., 1997).  Hospitalization is indicated 
for patients who have failed to benefit from less intensive levels of care or under the following 
conditions: medical instability, high suicidal intent, body weight less than 85% of ideal or acute, 
rapid weight loss, poor motivation to recover as indicated by treatment resistance, the need for 
supervision during and after meals, and severe family conflict or lack of an adequate support 
system (LaVia et al., 1997).  
Although indications for inpatient treatment of patients with AN have been defined, 
research evidence supporting the long-term efficacy of inpatient treatment for AN is lacking.  
Pike (1998), in her review of studies of long-term outcome, reported that between 30% and 50% 
of patients discharged from an inpatient unit to outpatient care relapsed and required readmission 
to an inpatient unit. Clinical concern related to the inadequacy of inpatient and traditional 
outpatient care for patients with AN, combined with managed care pressures to reduce use of 
inpatient care, have led to the development of alternative levels of care.  The partial hospital 
program (PHP) is one such alternative being developed and used for patients with eating 
disorders.   
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PHPs for patients with eating disorders provide intensive treatment and typically have 
treatment objectives similar to those of an inpatient unit.  Treatment is usually provided on a 5-7 
day per week basis, but PHPs differ from inpatient treatment in that they are not 24-hour per day 
treatment, and thus require that patients be medically and psychiatrically stable enough for 
outpatient care.    
The structure of PHPs for patients with eating disorders varies widely.  There are 
descriptions of PHPs for eating disorders; however, little is known about how this care is 
delivered and the effect of this level of care on AN treatment outcome.  The few studies 
describing the utility of PHPs for patients with AN reported in the literature report mixed 
findings.  Some studies suggest that PHP is an effective treatment for achieving weight gain and 
symptom relief in patients with AN, at least in the short term (Gerlinghoff, Backmund & 
Franzen, 1998; Piran et al., 1989; Williamson et al., 2001).  These studies however, describe a 
10-12 week average length of stay in PHP, which may be incompatible with current limitations 
of public and private insurance.  Moreover, the Williamson et al. (2001) report of positive 
outcome was for a generally healthier group, i.e., patients admitted to PHP at higher weights and 
not having had inpatient treatment immediately prior to admission to PHP.   
Less positive findings are reported by Howard, Evans, Quintero-Howard, Bowers, and 
Andersen (1999), who studied patients with AN who were discharged from an inpatient unit to 
PHP to identify prognostic indicators for success in PHP.  Their findings suggest that duration of 
illness greater than 6 years is associated with short-term treatment failure.  Moreover, they add 
support for findings from other studies (i.e., Deter & Herzog, 1994; Heberbrand et al., 1997 and 
1996; Richard, Bauer, & Kordy, 2005) that report longer durations of illness as being associated 
with long-term negative outcome, including chronic AN and death, and thus support the 
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inclusion of duration of illness as a potential predictor of readmission in the current study.  
Moreover, they report a combined length of treatment (inpatient and PHP) of approximately 91 
days and a significantly slower rate of weight gain in PHP than in inpatient care, suggesting that 
PHP treatment is neither clinically nor cost effective for the average patient. Also of significance 
is their conclusion that PHP appears to be most effective for patients discharged from inpatient 
care at weights of 90% or more of healthy weight.   
The implications of these findings are of particular concern in light of the abbreviated 
length of inpatient stay commonly associated with a managed care environment.  The restrictions 
imposed currently on duration of hospitalization would preclude the optimal length of stay 
described in the Howard et al. (1999) study and preclude in most cases the attainment of weight 
gain to 90% of healthy weight.   
PHP for patients with AN is a potentially useful alternative to inpatient care; however, its 
long-term clinical and cost effectiveness have not yet been established (Zipfel et al., 2002).  
Research is needed to determine for whom and under what conditions PHP would be an effective 
treatment setting for AN. 
Residential treatment is another potential alternative to inpatient care (APA, 2006).  
Residential care is intended for patients who need longer term care, but who do not have acute 
medical or psychiatric symptoms necessitating inpatient treatment.  Residential treatment is 24-
hour, non-hospital based care, and is generally provided by a multidisciplinary team.  Eating 
disorder residential treatment facilities are generally for-profit enterprises that are not covered by 
private or public insurance.  In the only known study of eating disorders residential care in the 
United States, Frisch, Herzog and Frankel (2006) surveyed 22 facilities and found that this level 
of care has seen rapid growth in the last decade, with a substantial increase in the number of 
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residential programs occurring between 2000 and 2004. The programs surveyed varied widely in 
approach and are described as having an average length of stay of 83 days at an average daily 
cost of $956.  The daily cost of residential programs reported in this study is similar to that 
reported for inpatient care.  The lack of insurance coverage for residential treatment and their 
high cost would require patients or families to have substantial financial resources in order to 
access this level of care.  The study also noted that there were no established standards of care 
for residential treatment and identified the need for standardization and regulation by external 
licensing bodies.  Moreover, they noted the lack of residential treatment outcome research and 
the crucial need for such research in light of the proliferation, length and expense of such 
programs (Frisch et al., 2006).  
The empirical database for outpatient individual treatments for AN is very limited.  Eight 
controlled trials with a total sample size of about 400 represents the extant empirical literature 
for psychosocial treatments for AN.  There is no evidence to support the efficacy of any 
particular form of outpatient treatment for patients with AN who are underweight (APA, 2006).  
There is preliminary support for the use of cognitive behavioral therapy with weight-restored 
adults (Pike, 2003). 
There is some evidence to support the use of family therapy with adolescent patients 
diagnosed with AN.  In a study done at the Maudsley Hospital in London, Russell, Szmuckler, 
and Eisler (1987) found family therapy to be superior to individual therapy for patients with AN 
younger than 19 years of age and who had a duration of illness of less than 3 years.   Based on 
this work, Dare and Eisler (1997) developed a specific form of family treatment for adolescents 
diagnosed with AN called the Maudsley approach.  This approach is contrary to the traditional 
stance in AN family treatment of viewing families as pathological and as causing or maintaining 
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AN symptoms in the patient. The Maudsley approach specifically avoids any direct or implied 
suggestion of blame and puts parents, rather than clinicians, in charge of their child’s refeeding.  
Since Russell’s et al. (1987) description of this approach, three subsequent controlled trials 
examining aspects of the Maudsley approach have added support for its use (Dare, Eisler, 
Russell, Treasure, & Dodge, 2001; Eisler et al., 2000; leGrange, Eisler, Dare, & Russell, 1992). 
The Maudsley approach has also been published in manual form (Lock, leGrange, Agras, & 
Dare, 2001).        
2.4.9 Psychopharmacology 
There are no known effective psychotropic interventions for patients diagnosed with AN 
who are underweight.  Medication can be used to treat associated symptoms, however in one 
study of antidepressant medication, fluoxetine, a select serotonin reuptake inhibitor (SSRI), was 
found to be beneficial for reducing episodes of relapse, improving weight maintenance and 
decreasing depressive symptoms (Kaye et al., 2001).  A subsequent study of the use of fluoxetine 
with patients who have AN, however, failed to demonstrate any positive effect on relapse or 
weight maintenance (Walsh et al., 2006).   
There is preliminary support for the use of second generation antipsychotic medications 
to promote weight gain and to treat associated symptoms of AN such as obsessionality, limited 
insight, anxiety, and psychotic-like thinking in adults and adolescents; however, evidence is 
based on case reports, case series and open-label uncontrolled trials (Gaskill, Treat, McCabe, & 
Marcus, 2001; LaVia, Gray, & Kaye, 2000).  Further research utilizing controlled trials is needed 
to evaluate the efficacy of second-generation antipsychotic medication in the treatment of AN.   
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2.4.10 Preliminary Studies 
The current study is third in a series of studies by our multidisciplinary team at Western 
Psychiatric Institute and Clinic to examine the effect of the shortened length of inpatient stay on 
the short- and long-term outcomes of patients with AN. As part of an academic medical center, 
our treatment center has access to large numbers of patients with AN who otherwise are difficult, 
if not impossible, to locate and study in sufficient numbers.  Our team of clinical researchers 
designed and developed the treatment-outcome database which allowed us in two initial studies 
to describe current AN inpatient treatment practices at our treatment center and to predict short-
term outcomes, and which allows me to examine predictors of long-term outcome in my 
dissertation research.   
Our initial study described details of the inpatient treatment that patients with AN 
received in the current care environment and documented the notably shorter length of inpatient 
stay (37.95 days); the lower weights at discharge (approximately 85% of ideal body weight); the 
existence of unresolved, non-acute medical issues at discharge; and the lack of improvement on 
psychological correlates of eating disorders at discharge (Treat et al., 2005). The patients 
described in this initial study remained quite ill at discharge and clearly did not meet the criteria 
established by Pike (1998) to indicate a satisfactory initial response to treatment.  Importantly, 
this study illustrated the disparity between established best practice standards and practice that is 
attainable in a managed care environment.  Moreover, given that patients at discharge showed 
markedly worse outcomes than observed after much longer inpatient treatment stays, this study 
highlights the importance of characterizing short- and long-term outcomes of inpatient 
hospitalization in the current environment, and examining factors associated with better or worse 
outcome over time. 
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Our second study documented the short-term outcome of patients with AN who 
completed this inpatient treatment in approximately 5 weeks and then were discharged directly to 
and treated in our eating disorders-specific PHP for approximately 3 weeks (Treat et al., under 
review).  At discharge from PHP, 35.2% of patients showed excellent outcomes, whereas 23.9% 
exhibited poor outcomes.  Patients who displayed excellent outcomes at PHP discharge showed 
higher weights and less AN psychopathology at both admission to and discharge from inpatient 
care, fewer previous psychiatric hospitalizations, shorter duration of illness, and younger age. At 
6-months post discharge from PHP, 52.1% of patients who had continued to receive outpatient 
treatment in our setting had been referred back to a higher level of care.  Those patients who did 
not require readmission to a higher level of care had been admitted to inpatient at higher weight, 
had fewer previous hospitalizations, were younger, were viewed by staff as more committed to 
treatment, endorsed less AN psychopathology at inpatient admission and discharge, and showed 
greater weight gain during PHP.  Two variables, number of previous admissions and weight gain 
in the first 5 days of PHP, correctly predicted almost 90% of outcome classification 6 months 
after PHP.  These findings provide the initial evidence on predictors of short-term outcome for 
patients with AN who have received an abbreviated dose of inpatient treatment, and begin to 
document for whom and under what conditions PHP is a useful step-down treatment after 
inpatient hospitalization.  
2.4.11 Current Study 
The present study examines inpatient readmission as an index of long-term outcome for inpatient 
treatment of AN that occurs in a managed care climate in which shortened length of stay and 
lower discharge weight have become the norm.  As previously described, the widespread 
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implementation of managed care practices has redefined the treatment landscape and forced a 
reconsideration of inpatient treatment objectives. The managed care environment precludes our 
ability to adhere to the established benchmarks historically achieved during hospitalization: 
attainment of 90% of ideal body weight, substantial decrease in excessive concern about and 
overvaluation of weight and shape, resumption of menses, substantial improvement in eating and 
compensatory behaviors, and resolution of medical problems as indicators of a satisfactory initial 
response to treatment (Pike, 1998).  Consequently, the previously studied benchmarks can no 
longer be applied to the current care environment.  The findings from the current study will 
provide important information about the outcomes of patients with AN in an era of shortened 
inpatient treatment stays, information presently absent in the literature.  
The current study will further inform our understanding of the longer-term outcomes of 
patients with AN treated in this era of abbreviated inpatient stays by characterizing one critical 
aspect of long-term outcome – namely, readmission to inpatient care – and examining predictors 
of this aspect of long-term outcome.  The first two studies focused on short-term outcomes; the 
first study examined and described patient characteristics at discharge from inpatient treatment 
and the second study examined patients at discharge from PHP and 6-months after completion of 
PHP.  This study extends the work done in the first two studies by examining patient outcomes 
over a longer period of time to determine the occurrence of readmission for AN treatment within 
3 years following the index admission. Moreover, this study will examine numerous potential 
predictors of readmission, including age, number of prior eating disorders psychiatric 
admissions, duration of illness, and percent of ideal body weight at admission to and discharge 
from inpatient treatment.  Psychiatric symptoms such as eating disorder and depressive 
symptoms, difficulties in interpersonal functioning, and the presence of additional Axis I 
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diagnoses will also be examined as potential predictors of readmission.  Consistent with findings 
reported in the previously described AN literature, it is hypothesized that more previous 
admissions, longer duration of illness, greater psychiatric symptomatology, and lower percent of 
ideal body weight at admission and discharge from inpatient will predict readmission to the 
inpatient level of care.   
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3.0  METHODS 
3.1 PARTICIPANTS 
The sample for the current study consists of 147 patients diagnosed with AN who were admitted 
consecutively to the Eating Disorders Unit at UPMC Western Psychiatric Institute and Clinic 
over a 22-month period of time from January 2000 to November 2001.  All patients who were 
admitted to the eating disorders unit during this time period and who had a primary diagnosis of 
AN were included in the study.  Analyses were conducted on both the full sample (n = 147) and 
the subset of patients who were subsequently readmitted to the WPIC inpatient eating disorders 
unit within 3 years of their discharge (n = 40) (See Figure 1).  Analyses were also conducted on a 
subsample of patients consisting of only those patients who were not discharged from inpatient 
treatment against medical advice (n = 107).  That is, they were judged by the treatment team to 
have received an adequate dose of treatment (See Figure 2). This study examines only those 
patients who were readmitted to the WPIC eating disorders unit; no information is available 
regarding whether or not patients were readmitted to other eating disorders treatment facilities.  
Data for this study were collected as part of a clinical pathways project designed to 
develop a best practice description of inpatient eating disorders treatment.  The pathways project 
was a WPIC-wide quality initiative that identified, described, and assessed routine clinical care 
procedures with the intent of enhancing the quality of clinical care. Thus, patient permission was 
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not sought as these data were originally obtained in the course of routine clinical care.  All self-
report questionnaires were included as part of the assessment procedures conducted at the time of 
index admission and discharge.  All remaining data were complete as they were obtained from 
review of the patient’s medical record.  Approval for the current project was obtained from the 
Biomedical Review Board of the University of Pittsburgh, after it was determined that these data 
would be used for research purposes (i.e. for wider dissemination and publication in the 
treatment outcome literature).  
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social workers, and psychiatric 
hly structured, with an emphasis on 
shaping and reinforcement of appropriate behaviors. Weight gain is a primary treatment 
objective; there are 5 scheduled meals per day.  Psychological interventions are delivered 
primarily in a group therapy format.  Groups are intended to provide psychoeducation to patients 
regarding the various medical, psychological, and interpersonal aspects of eating disorders and to 
teach the skills designed to enhance the self-management of their disorder.  For example, group 
topics include aspects of cognitive behavior therapy, dialectical behavior therapy skills, meal 
planning, and medical complications of eating disorders.  Patients are expected to participate in 
all meals and group sessions; failure to do so results in privileges being withheld and may result 
in other behavioral or medical consequences.    Patients follow a structured meal plan, and 
cognitive behavioral strategies are utilized to maintain a supportive and recovery-oriented milieu.  
Patients are placed on a disorder-specific pathway based on  AN subtype, i.e., AN restricting 
type or AN purging type.   
Patients on the disorder-specific protocols optimally progress through four treatment 
phases.  The Orientation Phase provides an introduction to the program and is expected to last 1-
2 days; patients remain in this phase until they are attending groups and have ceased purging 
behavior and restriction of food and fluids.  During the second phase of treatment, Pre-Self-
Select, patients select their food from a menu which is then provided to them on trays delivered 
to the inpatient unit.  This phase continues until patient weight is >80% IBW, daily calorie 
consumption is >2000, and there is no secretive exercising or ritualized eating behavior.  Length 
of stay in this phase is anticipated to be 14-28 days.  During the third phase of treatment, Self-
Select Phase, patients select their food in a hospital cafeteria.  This phase of treatment ends when 
appropriate foods are selected consistently and weight gain is stable at >1 kg per week.  This 
phase is anticipated to last 7-10 days.  During the final phase of treatment, Discharge Phase, 
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patients complete at least one meal session, a daylong therapeutic pass outside of the hospital, 
and a shopping/cooking outing.  This phase is expected to last 5-7 days.  Advancement criteria 
between treatment phases are presented in Table 1. 
All patients also are placed on a medication pathway, which details pharmacological 
strategies for managing symptoms associated with eating disorders, such as anxiety or mood 
lability. 
 
 
Table 1.  Criterea for Advancement to Next Inpatient Treatment Phase 
Advance to Pre-Self-Select Phase 
WHEN eating 100%, drinking minimum required fluids, attending groups, participating in family 
therapy (if applicable), completing treatment paperwork, and not purging 
Advance to Self-Select Phase 
WHEN patient continues to meet preceding advancement criteria, obtains 80% of target weight, 
eats at least 2000 cal per day and engages in no secretive exercising or extremely inappropriate or 
ritualized eating behavior (e.g., excessive or extremely inappropriate or ritualized eating behavior 
(e.g., excessive cutting, excessive chewing or holding food in mouth, excessive mixing) 
Advance to Discharge Phase 
WHEN patient continues to meet preceding advancement criteria, eats appropriate exchanges 
while self-selecting, and continues to gain at least 1 kg per week 
Advance to Discharge 
WHEN patient continues to meet preceding advancement criteria, and successfully completes at 
least 1 therapeutic pass, meal session, and shopping/cooking outing (if applicable OR IF 
discharge therapeutically indicated) 
 
3.2.1 Procedures 
During the 22-month period from January 2000 to November 2001 patients who were admitted 
to the eating disorders unit at UPMC Western Psychiatric Institute and Clinic with a primary 
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diagnosis of AN were asked to complete four self-report questionnaires: the Eating Disorders 
Examination-Questionnaire (EDE-Q; Fairburn & Beglin, 1994), the Eating Disorders Inventory-
2 (EDI-2; Garner, 1991), the Beck Depression Inventory-2 (BDI-2; Beck, Steer, & Brown, 
1996), and the Inventory of Interpersonal Problems (IIP; Horowitz, Rosenberg, Baer, Ureno, & 
Villaseno, 1988).  Descriptions of the questionnaires are provided in the Measures section.  Staff 
explained that the questionnaires were part of a project to monitor and enhance clinical care and 
would provide detailed information regarding the symptoms with which patients present.  Staff 
provided instructions for questionnaire completion to patients and were also available during the 
time patients completed the questionnaires to provide assistance if needed. Other than 
completing the questionnaires, patients participated in treatment as usual; no alterations were 
made to their treatment plans as a result of their completion of the questionnaires. During the 
week prior to discharge patients again were asked to complete three of the four questionnaires: 
the EDI-2, the BDI-2, and the IIP.  Additional information regarding the other variables of 
interest was obtained by reviewing the medical record.  Data gathered from the self-report 
questionnaires and chart reviews were entered into a database developed for this project.   
The medical records of all patients were later reviewed to determine if patients had been 
readmitted to UPMC Western Psychiatric Institute and Clinic within 3 years of their index 
admission.   
3.2.2 Measures 
3.2.2.1 Self-Report.   
The four questionnaires completed at admission were: (a) the EDE-Q, a 34-item measure that 
assesses behavioral and psychological symptoms of eating disorders such as frequency of use of 
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compensatory behaviors (e.g., binge eating, purging), and preoccupation with weight, shape, 
eating, and dietary restraint during the last 28 days; (b) the EDI-2, a 91-item scale that provides 
information on dietary restraint, bulimic symptoms, body dissatisfaction, perfectionism, and 
ineffectiveness; (c) the BDI-2, a 21-item questionnaire designed to assess the severity of 
depressive symptoms; and (d) the IIP, a 47-item scale used to assess personality styles.  At 
discharge, patients again were asked to complete the EDI-2, the BDI-2, and the IIP.  Patients did 
not complete the EDE-Q again, because the 28-day time frame specified in the majority of the 
questions exceeded the length of stay for a substantial number of patients.   
3.2.2.2 Diagnostic Information.  
The nurse manager of the inpatient unit documented psychiatric diagnoses based on criteria in 
the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV: APA, 
1994).  Diagnostic information was based on clinical interviews with and observations of the 
patient, as well as on medical evaluations, including laboratory and EKG assessments.  Patients 
received diagnoses of AN with purging subtype (AN-P) or restricting subtype (AN-R).  Female 
patients of menarcheal age were not required to exhibit amenorrhea to receive an AN diagnosis 
on our unit.  This stance is consistent with literature suggesting that the amenorrhea criterion is 
unnecessary (Cachelin & Maher, 1998; Mitchell, Cook-Meyers, & Wonderlich, 2005).  AN 
diagnoses were later cross-checked by verifying that all patients who received an AN diagnosis 
weighed less than 85% of ideal body weight on admission.  Axis II diagnoses were deferred for 
all patients throughout inpatient treatment unless preexisting information documenting the 
presence of an Axis II diagnosis was available.  Because this information was available for only 
a subset of patients, it was not included in the analyses.  The practice of deferring personality 
disorder diagnosis during an inpatient hospitalization is consistent with the consensus of clinical 
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practice and opinion that suggests that patient functioning during an acute psychiatric crisis or at 
very low body weight is not a valid representation of patient functioning in general and should 
not be used as a basis for diagnosing personality disorders.  However, included in the analysis 
will be information obtained from the IIP, the self-report measure assessing personality styles 
and assessed to be a valid measure of maladaptive personality styles associated with 
interpersonal dysfunction.  
3.2.2.3 Other Clinical Information.   
Historical and demographic information was obtained from patient medical records at admission 
and included onset and duration of eating problems, frequency of previous psychiatric 
hospitalizations, height, education, race, marital status, gender, and age.  Nursing staff monitored 
and recorded in the medical record weight, prescribed calories, and medication usage throughout 
treatment.   
3.3 DATA PREPARATION AND ANALYSES 
Data was complete for almost all analyses, except for those based on the self- report 
questionnaire data, for which approximately 20% of the data were missing.   Complete data were 
available, with the exception of self report questionnaire data, because it was gathered 
throughout the course of routine clinical care, documented in the medical record, and later 
obtained via medical record review.  To increase power, missing questionnaire data was imputed 
and out-of-range estimates were replaced with the most extreme appropriate score for that 
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variable.  Little’s test was used to evaluate whether the missing data could be treated statistically 
as missing completely at random. 
3.3.1 Description of Full Sample at Admission 
The clinical characteristics of the full sample (n=147) on admission to the inpatient unit is 
presented in the text and in tables.  Tables present univariate descriptive statistics for the full 
sample at admission.  Means and standard deviations are presented for continuous variables (e.g., 
duration of illness, number of previous admissions, body mass index (BMI), percent ideal body 
weight, and self-report measures); frequencies and percentages are presented for discrete 
variables (e.g., AN diagnostic sub-type, comorbid diagnoses, and use of medications).    
3.3.2 Description of Pre-Post Inpatient Treatment Changes for Full Sample 
The next phase of analyses examined changes in the clinical characteristics of the full sample 
over the course of inpatient treatment.  Given the non-normal nature of most distributions, 
Wilcoxon and McNemar bivariate procedures were used to evaluate whether continuous and 
discrete variables changed over the course of the index admission.  Results are presented in the 
text and in tables.  
3.3.3 Description of Readmission Sample 
The next phase of analyses described the clinical characteristics of the readmission sample 
(n=40) and differences between the readmitted and non-readmitted groups on all variables.  
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Mann-Whitney and chi-square bivariate procedures were used to examine whether index 
admission variables differed as a function of readmission status.  Differences between the groups 
on each of the variables are presented in text and table form. 
3.3.4 Prediction of Readmission  
All demographic and clinical variables that were available on index inpatient admission and 
discharge were evaluated as potential predictors of readmission.  Potential predictors that were 
examined include age, number of prior eating disorders psychiatric admissions, duration of 
illness, and percent of ideal body weight at admission to and discharge from inpatient treatment.  
Additionally, psychiatric symptoms including eating disorder and depressive symptoms, 
difficulties in interpersonal functioning, and presence of additional Axis I diagnoses were 
examined as potential predictors of readmission (see Table 2).   
 
Table 2.  Examined Predictors of Whether Readmitted or Time to Readmission 
AN subtype (purging vs restricting) 
Duration of Eating Disorder 
Number of Previous eating-disorder hospitalizations 
Inpatient length of stay 
Inpatient weight gain per week (kg) 
Medication at inpatient discharge (present or absent) 
Mood stabilizers 
Selective serotonin reuptake inhibitors (SSRIs) 
Second-generation anti-psychotics 
Anxiety (either fast- or slow-acting benzodiazepines) 
Age 
Weight variables (at admission and discharge) 
BMI 
Percent-ideal BMI 
Comorbidity information at inpatient discharge (present or absent) 
Mood disorder diagnosis 
Anxiety disorder diagnosis 
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Table 2 (cont’d) 
Inventory of Interpersonal Problems subscale scores (admission and discharge) 
Interpersonal Sensitivity 
Ambivalence 
Need for Social Approval 
Lack of Sociability 
Personality Disorder Detection 
Eating Disorders Inventory subscale scores (admission and discharge) 
Drive for Thinness 
Bulimia 
Body Dissatisfaction 
Beck Depression Inventory score (admission and discharge) 
Eating Disorders Examined subscale and global scores (admission only) 
Restraint 
Weight Concern 
Shape Concern 
Eating Concern 
Global 
 
 
Finally, all significant predictors of readmission status in bivariate analyses were 
included in multivariate logistic-regression and survival analyses.  The distributions of all 
continuous variables were evaluated for normality on the basis of both visual inspection of the 
histograms and the skewness coefficient.  Grossly non-normal distributions were transformed so 
that the distributions were more appropriate for parametric analyses.  A natural-log or square-
root transformation was used whenever possible, and variables with distributions that could not 
be transformed to rough normality were converted into discrete variables.  The transformed data 
were used in the multivariate statistical analyses, but the untransformed data are presented in the 
text, tables, and figures, for ease of interpretation and comparison with the values presented in 
other reports.  
Logistic regression was used to evaluate the relative and cumulative predictive power of 
the significant predictors of readmission within three years of inpatient discharge.  These 
analyses evaluated whether the likelihood of readmission varied as a function of various 
predictors.  As noted above, preliminary non-parametric bivariate analyses were used to screen 
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potential predictors.  All significant bivariate predictors that passed a multicollinearity screening 
(i.e., that do not correlate too strongly with one another) were then included in a multivariate 
regression model.   
Survival analysis was used to evaluate predictors of “survival time,” or the number of 
days until readmission.  In contrast to the logistic-regression analyses, the survival analyses 
evaluated whether the length of time until readmission varied as a function of different 
predictors. All participants’ data were included in the analysis, including those who did not 
experience the target event of interest (i.e., readmission) during the three-year assessment 
window after inpatient discharge.  After screening all potential predictors in preliminary 
bivariate survival analyses, significant bivariate predictors that passed a multicollinearity 
evaluation were included in the multivariate survival analysis model.  A simultaneous-entry 
method was again used to select predictors for the final model. 
3.3.5 Re-analysis of Research Questions for Patients Who Received an Adequate Dose of   
           Treatment  
All analyses described above were conducted on a subsample of patients (n = 107) consisting of 
those patients who were not discharged against medical advice and thus received an adequate 
dose of treatment.  This subset of patients is arguably more representative of those who have 
received an adequate dose of treatment in the current care environment and are thus a better 
group from which to identify predictors of readmission.   
 49 
4.0  RESULTS 
4.1 DATA PREPARATION AND ANALYSES 
The distributions of the majority of the variables were markedly skewed and could not be 
transformed to normality without discretizing the variables.  Thus, all reported analyses employ 
non-parametric statistical methods, except where noted (i.e., logistic regression and survival 
analyses).  Means and standard deviations are presented in the text and tables to maximize 
comparability with other reports.  All reported p-values are based on two-tailed tests.  Data were 
complete for all analyses, except for those based on the self-report questionnaire data.  Missing 
data were imputed using the Expectation-Maximization algorithm procedure provided by SPSS, 
and out-of-range estimates were replaced with the most extreme score possible for that variable.  
The following variables were used to impute the missing values:  length of stay, age, weight gain 
per week, number of previous hospitalizations for an eating disorder, BMI and % IBW at 
admission and discharge, calories at admission and discharge, reported duration of eating 
disorder, and AN subtype.  Little’s test suggested that the missing questionnaire data were 
missing completely at random, χ2(835) = 901.722, p = .054, which justified the use of 
imputation methods to increase the power of analyses involving the questionnaire data.  Across 
the full sample (n = 147), the percentages of missing data were as follows:  18.4% and 24.5% for 
the EDI-2, at admission and discharge, respectively.   29.9% and 24.5% for the BDI-2 at 
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admission and discharge, respectively, and 18.4% for the EDE-Q at admission. 20.4% and 21.1% 
for the IIP at admission and discharge, respectively.        
4.1.1 Description of Full Sample 
The majority of participants were female (94.6%), Caucasian (98.0%), single (87.8%), and 
hospitalized voluntarily throughout treatment (95.2%).  Average age was 21.15 years (SD = 9.11, 
Median = 17.57).  41.5% percent reported at least one prior psychiatric hospitalization, and 
patients reported an average symptom duration of 5.26 years (SD = 6.76, Median = 2.37).  Table 
3 presents additional clinical information for the full sample on admission.  Average scores on 
the EDI-2, EDE-Q, and BDI-2 were similar to those for comparable samples of inpatients with 
eating disorders (e.g., Howard et al., 1999; Pike, 2000; Probst, Vandereycken, Coppenolle, & 
Pieters, 1999).   
 
 
 
Table 3.  Clinical Characteristics of Full Sample (n=147) on Admission to Inpatient Unit 
Variable Patients with  Characteristic 
 N % 
Diagnosis 
   AN-R 
   AN-P 
 
89 
58 
 
60.5 
39.5 
Comorbid Axis I Psychiatric Diagnosis 
   Any Unipolar Mood Disordera 
   Any Anxiety Disorderb 
   Any Psychotic Disorder 
 
61 
31 
0 
 
41.5 
21.1 
0 
Medication 
   Anxiolytics 
   SSRIs 
   Second-Generation Antipsychotics 
   Mood Stabilizers 
 
22 
57 
18 
5 
 
15.0 
38.8 
12.2 
3.4 
 Mean SD 
Duration of eating disorder (years) 5.26 6.76 
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Table 3 (Cont’d) 
Body Mass Indexc 15.08 1.53 
Percent-Ideal Body Weight (%IBW)d 72.65 7.52 
Eating Disorders Inventory-2 
   Drive for Thinness 
   Bulimia 
   Body Dissatisfaction 
 
11.11 
1.94 
14.16 
 
7.20 
3.31 
8.54 
Eating Disorders Examination-Q 
   Restraint 
   Weight Concern 
   Shape Concern 
   Eating Concern 
   Global Score 
 
3.64 
3.37 
3.92 
2.96 
3.47 
 
1.94 
1.78 
1.77 
1.67 
1.68 
Beck Depression Inventory-2 
   Total Score 24.03 13.13 
Inventory of Interpersonal Problems 
   Interpersonal Sensitivity 
   Ambivalence 
   Aggression 
   Need for Social Approval 
   Lack of Sociability 
   Personality Disorder Detection 
 
1.69 
1.05 
.92 
2.15 
1.62 
1.22 
 
.88 
.75 
.64 
.97 
.90 
.63 
aMajor Depressive Disorder with or without psychotic features, Depressive Disorder NOS, Dysthymia 
bObsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Post-Traumatic Stress 
Disorder, Social Phobia, Specific Phobia, Anxiety Disorder NOS 
cWeight (kg) / Height2 (m) 
dAbsolute body mass index divided by the medium body mass index for a given age and sex, as specified 
on CDC growth charts (CDC,2000) 
Note:  SSRI = selective serotonin reuptake inhibitors; AN-P = anorexia nervosa-bingeing/purging      
        subtype; AN-R = anorexia nervosa-restricting subtype 
  
 
 
Weight is represented in the text and tables in terms of Body Mass Index (BMI) and percent 
ideal body weight (%IBW).  BMI is obtained by dividing weight in kilograms by height in 
meters squared (BMI = Weight(kg) / height2(m)). %IBW refers to the patient’s BMI divided by 
the median BMI for a specific age and gender, as specified by the Center for Disease Control 
(CDC, 2000).     
 
52 
4.1.2 Pre-Post Inpatient Treatment Changes for Full Sample (n=147) 
The average length of stay for the entire sample was 31.48 days (SD = 18.34, Median = 28).  
Patients gained an average of 1.30 kg per week (SD = .78). Patients were 72.65% (SD = 7.52) of 
ideal BMI at admission and 83.44% (SD = 6.53) of ideal body weight at discharge.   
As shown in Table 4, the percentage of patients who received comorbid diagnoses of 
either mood or anxiety disorders increased significantly from admission at discharge.  The 
increase in the number of Axis I diagnoses reflects unit policy to defer additional diagnoses until 
after patient stabilization and the initiation of re-nutrition, unless pre-existing information about 
the patient is available.   
As shown in Table 4, the percentages of patients who were admitted on four classes of 
medication were nearly identical at admission and discharge, except for a substantial and 
significant increase in the proportion of patients taking second-generation antipsychotic agents 
for the management of agitation and anxiety related to refeeding, from 12.2% to 42.3%.  The 
percentage of patients taking SSRIs also increased significantly from 38.8% to 52.4%.  Per the 
treatment protocol, patients who were admitted at less than 80% IBW were encouraged to 
discontinue SSRIs, consistent with evidence indicating lack of efficacy for SSRIs at low body 
weight (e.g., Attia, Haiman, Walsh, & Flater, 1998).  After achieving 80% of IBW, SSRIs were 
prescribed or re-prescribed, as appropriate, given the available evidence at the time suggesting 
their potential utility in weight maintenance and the management of mood and anxiety symptoms 
(e.g., Kaye, Nagata, Weltzin, Hsu, Sokol, McConaha, Plotnicov, Weise, & Deep, 2001).  
Subsequent studies have since demonstrated no effect on weight maintenance (Walsh et.al., 
2006); however, they substantiate the continued utility of SSRIs for the management of co-
existing mood and anxiety symptoms.  
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Average scores on the BDI-II and the Drive for Thinness and Bulimia subscales of the 
EDI-2, and Lack of Sociability subscale of the IIP decreased significantly over treatment.  The 
observed decrease in the Body Dissatisfaction subscale score was not significant.  
 
Table 4.  Pre-Post Inpatient Treatment Changes for Full Sample (n = 147) 
 Admission Discharge 
Variable Mean SD Mean SD 
Body Mass Indexab     15.08 1.53 17.32 1.29
Percent-Ideal Body Weight (% IBW)bc     72.65 7.52 83.44 6.53
Calories per dayb 1506.08 417.71 2905.10 541.14
Eating Disorders Inventory-2 
    Drive for Thinnessb 
    Bulimiab 
    Body Dissatisfaction 
 
    11.11 
      1.94 
1416
7.20 
3.31 
8.54 
8.75 
1.13 
13.33
6.66 
2.18 
8.10
Beck Depression Inventory-II 
    Total Scoreb 24.03 3.13 14.29 10.64
Inventory of Interpersonal Problems 
    Interpersonal Sensitivity 
    Ambivalence 
    Need for Social Approval 
    Lack of Sociabilityb 
    Personality Disorder Detection 
1.69 
1.05 
2.15 
1.62 
1.22
.88 
.75 
.97 
.90 
.63 
1.65 
1.13 
2.08 
1.47 
1.21
.86 
.83 
.95 
.88 
.68
 N % N % 
Comorbid Axis I Psychiatric Diagnosis 
    Any Unipolar Mood Disorderde 
    Any Anxiety Disorderdf  
    Any Psychotic Disorder 
61 
31 
0
41.5 
21.1 
0 
76 
68 
0
51.7 
46.3 
0
Medication 
    Anxiolytics 
    SSRIsd 
    Second-Generation Antipsychoticsd 
    Mood Stabilizers 
22 
57 
18 
5
15.0 
38.8 
12.2 
3.4 
20 
77 
62 
9
13.6 
52.4 
42.3 
6.1
aWeight (kg) / Height2 (m) 
bPre-post difference significant at p < .05, using Wilcoxon Test to compare medians at  
 admission and discharge 
cAbsolute body mass index divided by the median body mass index for a given age and sex, as  
 specified on CDC growth charts (CDC, 2000) 
dPre-post difference significant at p < .05, using McNemar Test to compare dependent  
 proportions 
eMajor Depressive Disorder with or without psychotic features, Depressive Disorder NOS,  
 Dysthymia 
fObsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Post- 
 Traumatic Stress Disorder, Social Phobia, Specific Phobia, Separation Anxiety Disorder,  
 Anxiety Disorder NOS 
Note:  SSRI = selective serotonin reuptake inhibitors; BMI  = Body Mass Index 
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4.1.3 Description of Readmission Sample 
The readmission sample consists of 40 patients, 27.21% of the full sample of 147.  Consistent 
with the full sample, the majority were female (92.50%), single (90%), and Caucasian (97.50%).  
50% of the readmitted patients had no prior hospitalizations at the time of the index admission, 
and 20% had 3 or more prior eating disorders inpatient admissions.  The total number of prior 
readmissions ranged from 0 to 12.  The average length of time to readmission was 285 days (SD 
= 309.93, median = 148.50) and ranged from 2 to 1065 days.  The average readmission weight 
was 73.70% of IBW (SD = 10.18, median = 74.70).  75% were readmitted at a weight of 80% of 
IBW or below.    
4.1.4 Prediction of Readmission: Logistic Regression Approach 
All demographic and clinical variables that were available on index inpatient admission and 
discharge were evaluated as potential predictors of readmission using Mann Whitney and Chi 
Square procedures.  Table 5 presents all significant findings.  Readmitted patients scored 
significantly higher than patients who were not readmitted on the Drive for Thinness and Body 
Dissatisfaction subscales of the EDI-2 at discharge.  Readmitted patients scored significantly 
higher on all subscales of the EDE-Q at admission.  The BDI-II scores for readmitted patients at 
admission and discharge were also significantly higher.   No significant differences emerged on 
any other variables, including weight, duration of illness, number of prior hospitalizations, 
presence of co-morbid psychiatric illness, and personality problems.    
Next, a logistic-regression model was used to evaluate the predictive power of this pool 
of significant correlates of readmission status.   As seen in Table 5, only scores on self-report 
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measures emerged as predictors of readmission status in the bivariate analyses.  The strong 
correlations among these scores posed a multicollinearity problem that would increase the 
standard errors of parameter estimates and jeopardize the statistical significance of the findings.  
Thus, only a single self-report measure was included in the logistic-regression model.  Because 
Body Dissatisfaction at inpatient discharge emerged as the single strongest predictor in the 
bivariate analyses reported in the previous paragraph, it was included as the self-report predictor 
of readmission status in the logistic-regression model.  Body Dissatisfaction was roughly 
normally distributed, so it was unnecessary to transform this variable prior to inclusion in this 
parametric analysis.  The Hosmer and Lemeshow goodness-of-fit test indicated that the model 
provided an adequate fit to the data, χ2(8) = 5.847, p = .664.  Body Dissatisfaction accounted for 
9.1% of the variability in readmission status, β = .074, p < .05.  This variable correctly predicted 
the readmission status of 25 of the 40 readmitted patients (62.5%) and 64 of the 107 (59.8%) of 
the patients who were not readmitted.   
 
Table 5.  Index Admission Variables for which Readmitted Patients (n=40) and Patients Who Were Not 
Readmitted (n=107) Differed Significantly 
 Readmitted Not Readmitted 
Variable Mean SD Mean SD 
Eating Disorders Inventory – 2 
    Drive for Thinness (d/c) 
    Body Dissatisfaction (d/c) 
11.13 
16.64
6.67 
7.24 
7.62 
12.09
6.43 
8.08
Eating Disorders Examination – Q 
Restraing (adm)    
Weight (adm) 
Shape (adm) 
Eating (adm) 
Global (adm)                                                                
4.17 
3.86 
4.41 
3.40 
3.97
1.80 
1.64 
1.67 
1.63 
1.60 
3.44 
3.18 
3.73 
2.79 
3.29
1.96 
1.80 
1.78 
1.66 
1.67
Beck Depression Inventory II 
Admission (sig) 
Discharge (sig) 
28.17 
17.22
12.64 
9.98 
22.48 
13.19
13.03 
10.71
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4.1.5 Re-analysis of Research Questions for Subsample of Patients Who Received an  
            Adequate Dose of Treatment (n= 107)  
The analyses were repeated for a subsample of patients that excluded those who left treatment 
against medical advice (AMA) – that is, those who clearly did not receive an adequate dose of 
treatment.    The rationale for excluding patients who left treatment prematurely is to provide a 
more valid description of the outcomes of patients who received an adequate dose of treatment in 
the current care environment.   
The average age of patients in this subsample was 20.57 years (SD = 9.14), and their 
mean duration of illness was 4.73 years (SD = 6.30).  59.8% of this subsample were diagnosed 
with restricting subtype of AN, and 40.2% were diagnosed with the purging subtype of AN.  The 
average length of stay for this subsample was 32.45 days (SD = 16.38, Median = 30).  See Table 
6 for a description of the clinical characteristics of the subsample. 
 
Table 6.  Clinical Characteristics of Subsample of Patients Who Received an Adequate Dose of Treatment 
(n=107) on Admission to Inpatient Unit 
 
Patients with 
Characteristic 
Variable N % 
Diagnosis 
     AN-R 
     AN-P 
64 
43 
59.8 
40.2
Comorbid Axis I Psychiatric Diagnosis 
     Any Unipolar Mood Disordera 
      Any Anxiety Disorderb 
     Any Psychotic Disorder   
45 
21 
0 
42.1 
19.6 
0
Medication 
     Anxiolytics 
     SSRIs 
     Second-Generation Antipsychotics 
     Mood Stabilizers 
14 
44 
15 
3 
13.1 
41.1 
14.0 
2.8
 Mean SD 
Duration of eating disorder (years) 4.73 6.30
Body Mass Indexc 15.28 144
Percent-Ideal Body Weight (%IBW)d 73.93 6.88
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Table 6 (Cont’d) 
EatingDisorders Inventory – 2 
     Drive for Thinness 
     Bulimia 
     Body Dissatisfaction 
 
12.22 
2.00 
14.61 
 
7.02 
3.39 
8.70
Eating Disorders Examination – Q 
     Restraint 
     Weight Concern 
     Shape Concern 
     Eating Concern 
     Global Score 
3.90 
3.59 
4.07 
3.11 
3.67 
1.85 
1.76 
1.78 
1.65 
1.64
Beck Depression Inventory-2 
     Total Score 24.89 12.74
Inventory of Interpersonal Problems 
     Interpersonal Sensitivity 
     Ambivalence 
     Aggression 
     Need for Social Approval 
     Lack of  Sociability 
     Personality Disorder Detection 
1.69 
1.07 
.93 
2.21 
1.56 
1.23 
.84 
.76 
.61 
.94 
.86 
.60
aMajor Depressive Disorder with or without psychotic features, Depressive Disorder NOS, Dysthmia 
bObsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Post-Traumatic Stres 
Disorder, Social Phobia, Specific Phobia, Anxiety Disorder NOS 
cWeight (kg) / Height 2 (m) 
dAbsolute body mass index divided by the median body mass index for a given age and sex, as specified 
on CDC growth charts (CDC, 2000) 
Note:  SSRI = selective serotonin reuptake inhibitors: AN-P = anorexia nervosa-bingeing/purging 
subtype; AN-R = anorexia nervosa-restricting subtype 
4.1.6 Pre-Post Inpatient Treatment Changes for Subsample Who Received an Adequate 
Dose of Treatment (n = 107) 
As shown in Table 7, percent ideal body weight increased significantly over the course of 
treatment from 73.93% (SD = 6.88) to 85.37% (SD = 5.56). Average scores on the Drive for 
Thinness and Bulimia subscales of the EDI-2 and the BDI II decreased significantly over the 
course of treatment.  There were no significant changes over the course of treatment on the Body 
Dissatisfaction subscale of the EDI-2 or any of the IIP subscale scores.   
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Table 7.  Pre-Post Inpatient Treatment Changes for Subsample of Patient Who Received an Adequate Dose 
of Treatment (n=107) 
 Admission Discharge 
Variable Mean SD Mean SD 
Body Mass Indexab     15.08 1.44 17.65 1.21
Percent-Ideal Body Weight (% IBW)bc 73.93 6.88 85.37 5.56
Calories per dayb 1543.87 448.20 3002.34 405.00
Eating Disorders Inventory-2 
    Drive for Thinnessb 
    Bulimiab 
    Body Dissatisfaction 
12.22 
2.00 
14.61
7.02 
3.39 
8.70 
9.41 
1.07 
14.04
6.67 
2.20 
8.29
Beck Depression Inventory-II 
    Total Scoreb 24.89 12.74 14.83 10.50
Inventory of Interpersonal Problems 
    Interpersonal Sensitivity 
    Ambivalence 
    Aggression 
    Need for Social Approval 
    Lack of Sociability  
    Personality Disorder Detection 
1.69 
1.07 
.93 
2.21 
1.56 
1.23
.84 
.76 
.61 
.94 
.86 
.60 
1.69 
1.09 
.87 
2.17 
1.54 
1.21
.83 
.77 
.74 
.91 
.84 
.66
 N % N % 
Comorbid Axis I Psychiatric Diagnosisd 
    Any Unipolar Mood Disorderde 
    Any Anxiety Disorderdf 
    Any Psychotic Disorder 
45 
21 
0
42.1 
19.6 
0 
57 
51 
0
53.3 
47.7 
0
Medication 
    Anxiolytics 
    SSRIsd 
    Second-Generation Antipsychoticsd 
    Mood Stabilizers 
14 
44 
15 
3
13.1 
41.1 
14.0 
2.8 
14 
63 
52 
6
13.1 
58.9 
48.6 
5.6
aWeight (kg) / Height2 (m) 
bPre-post difference significant at p < .05, using Wilcoxon Test to compare medians at admission and   
 discharge 
cAbsolute body mass index divided by the median body mass index for a given age and sex, as specified   
 on CDC growth charts (CDC, 2000) 
dPre-post difference significant at p < .05, using McNemar Test to compare dependent proportions 
eMajor Depressive Disorder with or without psychotic features, Depressive Disorder NOS, Dysthymia 
fObsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Post-Traumatic Stress   
 Disorder, Social Phobia, Separation Anxiety Disorder, Anxiety Disorder NOS 
Note:  SSRI = selective serotonin reuptake inhibitors; BMI = Body Mass Index 
 
4.1.7 Prediction of Readmission for Subsample of Patients Who Received an Adequate 
Dose of Treatment: Logistic Regression Approach  
All demographic and clinical variables listed in Table 2 were evaluated as potential predictors of 
readmission in preliminary bivariate analyses using Mann Whitney and Chi Square procedures.  
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Table 8 presents all significant findings.  Readmitted patients scored significantly higher than not 
readmitted patients on the Drive for Thinness and Body Dissatisfaction subscales of the EDI-2 at 
discharge.  Readmitted patients also showed higher scores on the Interpersonal Sensitivity, Lack 
of Sociability, and Personality Disorder Detection subscales of the IIP at discharge.   The BDI–II 
scores for readmitted patients at discharge also were significantly elevated.  Readmitted patients 
also differed significantly from the remaining patients on the presence of co-morbid psychiatric 
illnesses; readmitted patients displayed a significantly higher frequency of any unipolar mood 
disorder at discharge.  No other significant differences emerged on any other variables, including 
any of the subscales of the EDE-Q, weight, duration of illness, number of prior psychiatric 
hospitalizations, and medication usage.  
 
Table 8.  Index Admission Variables for Which Readmitted Patients (n=33) and Patients Who Were Not 
Readmitted (n=74) Differed Significantly Among Patients who Received an Adequate Dose of 
Treatment 
 Readmitted Not Readmitted 
Variable Mean SD Mean SD 
Eating Disorders Inventory – 2 
Drive for Thinness (d/c) 
Body Dissatisfaction (d/c) 
11.13 
16.64
6.67 
7.24 
7.62 
12.09
6.43 
8.08
Inventory of Interpersonal Problems 
Interpersonal Sensitivity (d/c) 
Lack of Sociability (d/c) 
Personality Disorder Detection (d/c)                           
1.95 
1.79 
1.40
.73 
.81 
.58 
1.57 
1.43 
1.13
.86 
.83 
.67
Beck Depression Inventory II 
Discharge (sig) 18.04 10.00 13.40 10.46
 N % N % 
Comorbid Axis I Psychiatric Diagnoses 
Any unipolar mood disorder (d/c) 23 69.7 34 45.9
 
A logistic-regression approach was used to evaluate the predictive power of this pool of 
significant bivariate correlates of readmission status.   Strong correlations among scores on self-
report measures again presented a multicollinearity problem and necessitated the inclusion of 
only a single self-report measure in the logistic-regression model.  Body Dissatisfaction at 
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inpatient discharge emerged as the single strongest predictor in the bivariate analyses of the 
subsample of patients who received an adequate dose of treatment.  Thus, only this self-report 
index was included in the logistic-regression model.  The presence or absence of any unipolar 
mood disorder at inpatient discharge also was included in the model.  Body Dissatisfaction was 
not transformed prior to conducting the analysis, as its distribution was roughly normal.  The 
Hosmer and Lemeshow goodness-of-fit test indicated that the model provided an adequate fit to 
the data, χ2(8) = 8.311, p = .404, and accounted for 12.0% of the variability in readmission 
status.  Body Dissatisfaction, β = .056, p < .05, and Mood Disorder, β = .854, p < .10, correctly 
predicted the readmission status of 20 of the 33 readmitted patients (60.6%) and 44 of the 74 
(59.5%) of the not readmitted patients. 
 
4.1.8 Prediction of Readmission: Survival Analysis Approach 
Cox-regression survival techniques were used to evaluate potential predictors of time to 
readmission (up to three years after inpatient discharge), whereas logistic-regression methods 
were used to examine prediction of the presence or absence of readmission within three years of 
inpatient discharge.  Please refer to Table 2 for a list of the predictors that were evaluated in 
preliminary bivariate analyses.  Figure 3 depicts the average survival curve for the full sample.  
The X axis presents the number of days since inpatient discharge, which ranges from 0 to 1095 
days.  The Y axis presents the probability of “surviving” readmission (i.e., the probability of not 
being readmitted).  Initially, this probability is 1.00 (i.e., no patients have been readmitted on the 
day of discharge), but it declines to .7279 by the end of 1095 days.  In other words, the 
percentage of patients who are readmitted within three years is 27.21, as noted previously.  Note 
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that most readmissions occur within one year of inpatient discharge.  Variability in the time to 
readmission serves as the dependent variable in all subsequent survival analyses.  This variable 
assumes values from 0 to 1095 for readmitted patients and has a “censored” value (which 
indicates that the readmission “event” has not yet occurred) for all remaining patients. 
 
Figure 3.  Average Survival Curve for the Full Sample (n = 147) 
 
MPlus was used to conduct all survival analyses, because this statistical package (but not 
SPSS) allows maximum-likelihood estimation of parameters with standard errors that are robust 
to non-normality.  Thus, it is unnecessary to transform variables with non-normal distributions 
prior to analysis.  Many of the potential predictor variables in the current data set were not 
transformable to roughly normal distributions without discretizing them, which eliminates 
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potentially useful information from analyses.  Thus, the use of MPlus to conduct survival 
analyses allowed the retention of more information about each variable. 
For each survival analysis, MPlus provides the unstandardized beta coefficients for the 
logistic-regression equation, the standard errors for the coefficients, and the estimates divided by 
their respective standard errors.  An estimate divided by its standard error provides a test statistic 
for the evaluation of the null hypothesis that the population parameter estimate (i.e., the 
population parameter corresponding to the beta coefficient) is zero.  The test statistic is known to 
adhere to a Z distribution, so values greater than +1.96 or less than -1.96 are significant at p = .05 
(two-tailed).  Odds ratios, which correspond to exponentiated beta coefficients, also are provided 
for each significant predictor.  Odds ratios indicate the odds of readmission for a 1-unit increase 
in a predictor.  For a dichotomous predictor, the odds ratio is readily interpretable.  For example, 
an odds ratio of 2.248 for any unipolar mood disorder at inpatient discharge indicates that earlier 
readmission (e.g., readmission 30 days post inpatient discharge rather than 500 days post 
inpatient discharge) is more than two times as likely for a patient who receives such a diagnosis 
on discharge.  For continuous predictors, it is useful to consider how the odds of readmission 
change with a greater increase in the value of a predictor.  For example, an odds ratio of 1.066 
for Body-Dissatisfaction subscale scores on the EDI-2 at inpatient discharge (i.e., 1.066 = 
e0.059) indicates that the odds of being readmitted are 1.066 times greater for a patient who 
scored one point higher than another patient on the Body-Dissatisfaction subscale of the EDI-2.  
This likely strikes the reader as a miniscule effect, but Body-Dissatisfaction scores range from 0 
to 27 in the current data set, whereas values of the mood-disorder variable are constrained to be 
either 0 or 1.  Note that the odds of readmission for a patient who scored 12 points higher on the 
Body-Dissatisfaction subscale is 2.030 times greater than it is for the patient scoring 12 points 
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less (i.e., 2.030 = e(12*0.059)).  Thus, the odds of earlier readmission are slightly more than two 
times greater for a patient who scores 12 points higher on the subscale at inpatient discharge. 
Survival Analysis for Full Sample 
Table 9 presents all significant findings from preliminary bivariate survival analyses on 
the full sample (n = 147).  Patients were significantly more likely to be readmitted earlier if they 
showed higher scores on the Drive-for-Thinness and Body-Dissatisfaction subscales of the EDI-
2 at inpatient discharge.  The likelihood of earlier readmission also increased as BDI-II scores 
increased at both inpatient admission and discharge.  Higher scores on most EDE-Q subscales, as 
well as the global score, predicted earlier readmission.  Earlier readmission also became more 
likely as the number of prior hospitalizations increased.  None of the remaining variables listed 
in Table 2 was associated with an altered likelihood of earlier readmission, including AN 
subtype, all weight-related variables, the duration of the eating disorder, medications on inpatient 
discharge, and presence of comorbid Axis-1 psychiatric diagnoses on inpatient discharge. 
 
 
Table 9.  Significant Survivor-Analytic Findings for Full Sample (n = 147) 
Variable 
Beta 
Estimate 
Standard Error 
of Estimate Z-score 
Odds 
Ratio 
Number of prior hospitalizations 0.146 0.058 2.507 1.157
Eating Disorders Inventory – 2 
     Drive for Thinness (discharge) 
     Body Dissatisfaction (discharge) 
0.064 
0.059
0.022 
0.018 
2.870 
3.219 
1.066 
1.061
Beck Depression Inventory-II 
     Total Score (admission) 
     Total Score (discharge) 
0.029 
0.026
0.012 
0.012 
2.443 
2.153 
1.029 
1.026
Eating Disorders Examination – Q 
     Restraint (admission) 
     Weight Concern (admission) 
     Shape Concern (admission) 
     Global Score (admission) 
0.174 
0.195 
0.206 
0.226
0.087 
0.091 
0.104 
0.106 
2.004 
2.153 
1.990 
2.136 
1.190 
1.215 
1.229 
1.254
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The nine significant bivariate predictors of time-to-readmission were considered for 
inclusion in a multivariate model.  Given the strong collinearity of scores on the self-report 
measures, only the Body-Dissatisfaction subscale of the EDI-2 at inpatient discharge was 
included.  Number of prior hospitalizations also was included, as it showed only a weak non-
parametric correlation with Body-Dissatisfaction scores (.256).    Body-Dissatisfaction scores 
significantly predicted time to readmission (B = 0.051, s.e. = .020, z = 2.540, odds ratio = 1.052), 
whereas number of prior eating-disorder hospitalizations was not a reliable predictor in a 
multivariate context (B = 0.086, s.e. = .068, z = 1.257, odds ratio = 1.090).  The Body 
Dissatisfaction effect can be observed in Figure 4, as the survival rate (i.e., the probability of not 
being readmitted) drops much more rapidly for patients with Body-Dissatisfaction scores that 
exceed the median. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Body Dissatisfaction Predictor of Time to Readmission in Survival Analyses for the Full Sample  
                 (n = 147) 
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4.1.9 Survival Analysis for Subsample Receiving Adequate Dose of Treatment 
Table 10 presents all significant findings from preliminary bivariate analyses on the subsample 
who received an adequate dose of treatment (n = 107).  Patients were significantly more likely to 
be readmitted earlier if they showed higher scores on the Drive-for-Thinness and Body-
Dissatisfaction subscales of the EDI-2 at inpatient discharge.  The likelihood of earlier 
readmission also increased as BDI-II scores increased at inpatient discharge.  Higher scores on 
two IIP subscales and the personality-disorder detection index of the IIP also predicted earlier 
readmission.  Finally, recipients of mood-disorder diagnoses on inpatient discharge were 
readmitted sooner.  None of the remaining variables listed in Table 2 were associated with an 
altered likelihood of earlier readmission, including AN subtype, number of prior hospitalizations, 
all weight-related variables, the duration of the eating disorder, medications on inpatient 
discharge, and presence of comorbid Axis-1 psychiatric diagnoses on inpatient discharge other 
than mood disorder. 
 
Table 10.  Significant Survivor-Analytic Findings for Subsample that Received Adequate Dose of Treatment 
(n=107) 
Variable 
Beta 
Estimate 
Standard Error 
of Estimate Z-score 
Odds 
Ratio 
Eating Disorders Inventory – 2 
     Drive for Thinness (discharge) 
     Body Dissatisfaction (discharge) 
0.061 
0.050
0.024 
0.019 
2.495 
2.566 
1.063 
1.051
Beck Depression Inventory-II 
     Total Score (discharge) 0.029 0.014 2.152 1.029
Inventory of Interpersonal Problems 
     Interpersonal Sensitivity (discharge) 
     Lack of Sociability (discharge) 
     Personality Disorder Detection (discharge) 
0.413 
0.387 
0.478
0.178 
0.189 
0.223 
2.324 
2.049 
2.137 
1.511 
1.473 
1.613
Comorbid Axis I Psychiatric Diagnosis 
     Any Unipolar Mood Disordera  (discharge) 0.810 0.380 2.133 2.248+
aMajor Depressive Disorder with or without psychotic features, Depressive Disorder NOS, Dysthymia 
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The seven significant bivariate predictors of time-to-readmission were considered for 
inclusion in a multivariate model.  Given multicollinearity concerns, only Body-Dissatisfaction 
at inpatient discharge was included from the set of self-report measures in the final model.  
Mood Disorder Diagnosis on inpatient discharge also was included, as it showed a non-
parametric correlation of only .207 with Body-Dissatisfaction scores.  In the multivariate model, 
Body Dissatisfaction significantly predicted time to readmission (B = 0.042, s.e. = .020, z = 
2.050, odds ratio = 1.043), and Mood Disorder Diagnosis showed a trend-level association with 
time to readmission (B = 0.663, s.e. = .397, z = 1.671, odds ratio = 1.941).  Figure 5 and Figure 6 
present these effects.  Note that the survival rate drops much more rapidly for patients with 
Body-Dissatisfaction scores that exceed the median and for patients who received a mood-
disorder diagnosis on inpatient discharge. 
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 Figures 5 and 6.  Body Dissatisfaction and Mood Disorder Diagnosis Predictors of Time to Readmission in 
Survival Analyses for the Subsample of Patients Who Received an Adequate Dose of 
Treatment (n = 107) 
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5.0  DISCUSSION 
Managed mental health care practices are widespread and have fundamentally altered the 
delivery of mental health services to both the privately and publicly insured.  Treatment services 
for serious and potentially chronic mental illnesses have been the most affected (Weissman, 
Pettigrew, Sotsky, & Reigier, 2000; Williamson, Thaw & Vernando-Sullivan, 2001; Wiseman, 
Sunday, Klapper, Harris & Halmi, 2000).  Managed care practices that limit access to and 
duration of care have particularly worrisome treatment and outcome implications for serious 
mental illnesses such as AN.   Research examining the outcome of patients who have serious 
mental illness and are treated in the current care environment is limited.   Given the magnitude of 
change to the mental health care delivery system, a reevaluation of outcome and predictors of 
outcome for patients with serious mental illness is critically important. This reevaluation is 
necessary because previous knowledge, upon which treatment decisions are made, may no longer 
be applicable to the current care environment.    
The present study examined one such group of patients with a serious mental illness, AN 
patients, and one indicator of long-term outcome, readmission. The overarching aims of this 
study were to describe the demographic and clinical features of patients who required multiple 
psychiatric inpatient hospitalizations for the treatment of AN and to identify patient 
characteristics that predicted readmission.  This characterization of AN patients and examination 
of predictors of readmission not only will inform  AN treatment, but also may shed light on 
factors that predict readmission for other patients who have serious mental illnesses, thus 
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informing efforts to evaluate and improve mental health treatments and service delivery across 
the spectrum of serious mental illnesses.   
The following discussion briefly summarizes the primary findings from the present study 
and then places these findings in the context of the relevant managed care and eating disorders 
literatures. The implications of the study’s findings for AN treatment, social work practice and 
policy development will next be discussed.  Finally, the strengths and weaknesses of the current 
study will be reviewed.  
5.1 BRIEF SUMMARY OF FINDINGS IN PRESENT STUDY 
The current research examined predictors of inpatient readmission for a sizable sample of 
patients diagnosed with AN who received inpatient treatment on the Eating Disorders Unit at 
UPMC Western Psychiatric Institute and Clinic.  Analyses were conducted on both the full 
sample of patients (n = 147; see Figure 1) and on a subsample of patients consisting of only 
those who received an adequate dose of treatment (i.e., they were not discharged from inpatient 
treatment against medical advice (n = 107; see Figure 2). Non-parametric tests and logistic-
regression techniques were used to identify predictors of whether readmission occurred (within a 
3 year period after discharge), and survival-analytic techniques were used to identify predictors 
of the time until readmission (up to 3 years after discharge).   We hypothesized that more 
previous admissions, longer duration of illness, greater psychiatric symptomatology, and lower 
percent of ideal body weight at index admission and discharge would predict both criterion 
variables (i.e., whether readmission occurred and whether it occurred sooner, rather than later), 
as these variables represent indicators of greater severity of illness that historically have been 
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associated with relapse and readmission.  Table 2 lists all variables that were evaluated as 
potential predictors of whether readmission occurred, as well as time to readmission. 
 
5.1.1 Full Sample Findings (n = 147).   
Non-parametric bivariate analyses demonstrated that readmitted patients reported greater 
depression, dietary restraint, and concern regarding weight, shape, and eating at the time of their 
index admission, relative to patients who were not readmitted.  At inpatient discharge, the 
readmitted patients continued to report more depression, dietary restraint, and body 
dissatisfaction than patients who were not readmitted.  Interestingly, no other variables predicted 
readmission status, including weight, duration of illness, number of prior hospitalizations, 
presence of co-morbid psychiatric illness, and personality problems.  In a multivariate logistic-
regression analysis, body dissatisfaction alone emerged as a significant predictor of readmission, 
accounting for 9.1% of the variability in readmission status.  Body dissatisfaction correctly 
predicted readmission status for 25 of 40 readmitted patients (62.5%), and 64 of the 107 patients 
(59.8) who were not readmitted.   
Survival-analytic bivariate analyses found patients were readmitted earlier if they 
reported greater dietary restraint and concern regarding weight and shape at their index 
admission, as compared to patients who were readmitted later.  Earlier readmission also was 
associated with patient reports at inpatient discharge of greater drive for thinness and body 
dissatisfaction.  Additionally, patients who reported greater depression at both admission and 
discharge were also more likely to be readmitted earlier.  Finally, as the number of previous 
admissions increased, earlier admission became more likely.  In a multivariate survival-analytic 
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model, only body dissatisfaction at inpatient discharge significantly predicted time to 
readmission (see Figure 4).  Across both sets of analyses, therefore, body dissatisfaction at 
inpatient discharge emerged as the strongest predictor of readmission status.  
5.1.2 Subsample Findings (n = 107).   
Parallel analyses were conducted on a subsample of patients who completed inpatient treatment 
(i.e., they were not discharged against medical advice). Thus, these patients were judged by the 
treatment team to have received an adequate dose of treatment.  This subsample of patients more 
closely represents the population of interest, that is, patients receiving adequate inpatient AN 
treatment in the current care environment.  As such, the findings from the subsample will be 
given greater emphasis in the subsequent discussion.  
Non-parametric bivariate analyses showed that, at inpatient discharge, readmitted patients 
reported greater drive for thinness and body dissatisfaction than patients who were not 
readmitted.  Moreover, readmitted patients reported more personality difficulties and depression, 
and they were more frequently diagnosed with unipolar depression.  We found no other 
significant group differences on any other variables, including concerns related to weight and 
shape, duration of illness, number of prior hospitalizations, and weight.  In the multivariate 
logistic regression analysis, body dissatisfaction emerged as a significant predictor of 
readmission status, with mood disorder as a trend-level predictor.  Together, these two variables 
accounted for 12% of the variability in readmission status.  This model correctly predicted the 
readmission status of 20 of the 33 readmitted patients (60.6%) and 44 of the 74 (59.5%) of the 
patients who were not readmitted.  
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Bivariate survival analyses found that patients were significantly more likely to be 
readmitted earlier if they reported greater drive for thinness, body dissatisfaction, and personality 
difficulties upon discharge from the index admission.  The likelihood of earlier readmission also 
increased as patient-reported depression at discharge increased.  Also, those patients who 
received a mood disorder diagnosis at discharge were more likely to be readmitted sooner. In the 
multivariate model, body dissatisfaction at inpatient discharge significantly predicted time to 
readmission, and mood disorder diagnosis showed a trend-level association with time to 
readmission (see Figure 5). Overall, the findings from the multivariate logistic regression 
analysis and survival analysis of this subsample are consistent; self-reported psychological 
features of AN, specifically body dissatisfaction, and mood disorder significantly predicted 
readmission status, the latter at a trend level in the survival analyses.   
5.1.3 Placing Findings in the Context of Managed Care and AN literatures 
The pattern of predictors found in the present study represents a departure from the typical 
pattern of predictors associated with readmission in AN. The existing empirical data base 
established body weight at both admission to and discharge from inpatient treatment as 
predictors of relapse and readmission (Baran, Weltzin & Kaye, 1995;  Heberbrand et al., 1996; 
Commeford, Licinio, & Halmi, 1997; Fichter & Quadflieg, 1999; Heberbrand et al., 1997; Lowe, 
et al., 2001; Pike, 1998; Steinhausen, Grigoroui-Serbanescu, Boyadjieva, Nuemarker,Metzke, 
2008; Zipfel, Lowe, Reas, Deter, & Herzog, 2000; Treat et al., under review).  Evidence also 
exists documenting duration of illness (Deter & Herzog, 1994; Fichter & Quadflieg, 1999; 
Richard, Bauer, & Kordy, 2005) and delay in treatment initiation (Steinhausen, 1995; Zipfel, 
Lowe, Reas, Deter, & Herzog, 2000) as predictors of relapse and readmission.  Willer, Thuras, 
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and Crow, (2005) have documented that increased length of stay, more rapid rate of weight gain, 
and prior hospitalizations were significant correlates of re-hospitalization; however after further 
analysis, increased length of stay was found to be correlated with more prior hospitalizations and 
lower body mass index at admission. An association between purging behavior and AN relapse 
has also been well established (Fichter & Quadflieg, 1999; Garner, & Rosen, 1993; Deter & 
Herzog, 1994; Eckert, Halmi, Marchi, Grove, & Crosby, 1995; Herzog & Schellberg & Deter, 
1997).  To a lesser extent, existing evidence also identifies greater severity of comorbid 
psychological problems as a predictor of poor outcome (Carter, Blackmore, Suander-Pinnock, & 
Woodside, 2004; Herzog & Schellberg & Deter, 1997; Lowe, et al., 2001).  
These previously identified predictors of readmission, when examined in the context of 
the current care environment in this study, were not found to predict readmission, excepting 
comorbidity, which sometimes has emerged as predictive of outcome.  In our analyses, we see 
the emergence in the bivariate analyses of the psychopathological aspects of AN, personality 
difficulties, and both self-reported and diagnosed mood disorder as significant predictors of 
readmission status. The multivariate logistic-regression and survival analyses identified body 
dissatisfaction and mood disorder as the most potent predictors of this subset of variables. This 
finding is typically not seen in the literature describing predictors of AN outcome, which as 
noted above, more commonly cites weight, presence of purging behavior, and duration of illness 
as predictors of readmission.  However, there are a few studies that document the presence of 
mood disorder and body image dissatisfaction as predictors of readmission (Eckert, Hami, 
Marchi, Grove, & Crosby, 1995; Hjern, Lindberg, & Lindblad, 2006; Keel, Dorer, Franko, 
Jackson & Herzog, 2005; Lowe et al., 2001), and we speculate that as more studies are 
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conducted on samples from managed care treatment environments, further support for these two 
predictors will emerge.        
This observed diminished effect of variables previously associated with readmission and 
the emergence of variables representing psychological distress as predictors of readmission may 
be understood in light of the changes in the care environment, specifically the shortened lengths 
of stay.  Our previous study (Treat et. al., 2005), which described the course of inpatient 
treatment of AN in the current care environment, documented that self-reported body 
dissatisfaction did not improve over the course of inpatient hospitalization and that significant 
improvement in other aspects of AN psychopathology was of a lesser magnitude than reported in 
studies evaluating longer durations of inpatient treatment (Bowers & Ansher, 2000; Channon & 
DeSilva, 1985; Grave, Bartocci, Todisco, Pantano, & Bosello, 1993; Pike, 2000; Probst, 
Vandereycken, Coppenolle, & Pieters, 1999; Steinhausen, 1985).  Findings from the current 
study bolster the importance of our previous findings by identifying the persistence of 
psychological distress associated with AN as being predictive of readmission.   
The continued difficulties with body dissatisfaction and mood may be related to the 
shortened lengths of stay characteristic of a managed care environment.  Readmission is clearly a 
negative outcome for patients, but it also may be an unintended outcome of managed care 
practices that limit duration of care for hospitalized AN patients (Kaye, Kaplan & Zucker, 1996; 
Williamson, et al., 2000).  Although hospital lengths of stays in this care environment are 
sufficient to initiate weight recovery, we speculate that they are not sufficient to promote 
psychological adjustment to and acceptance of weight gain and the associated changes in body 
shape and appearance.  Given the psychological features of AN (i.e., denial of the seriousness of 
weight loss, resistance to weight gain, fear of gaining weight and being fat, and body image 
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disturbance), it is not surprising that the approximate one month average length of stay described 
in the current study would be insufficient to produce substantial change in attitude toward weight 
gain or body size.  Patients have neither accepted the need for weight gain nor habituated to the 
changes in their body shape resulting from the weight gained while hospitalized.  They remain 
more depressed at discharge than patients who are not readmitted, and they may still be suffering 
the effects of cognitive impairment and diminished ability to regulate emotion.  Thus, at 
discharge, patients are in a heightened state of psychological distress secondary to their weight 
gain and, because of the abbreviated length of stay, are equipped with few of the psychological 
resources necessary to tolerate their distress and continue the process of treatment and recovery.   
The emphasis on weight attainment as the criterion for discharge, a by-product of the managed 
care environment, in the absence of equal attention to psychological readiness for discharge, may 
indeed be contributing to readmission.  This new pattern of predictors, which highlights the 
centrality of psychopathological aspects of AN and depressed mood to readmission, suggests a 
need to reconsider previously established readiness for discharge benchmarks and refine 
treatment interventions to more specifically target the psychological distress associated with 
body image disturbances and mood disorder.  
5.1.4 AN Treatment Implications     
The findings from this study have important treatment implications.  First, unlike predictors 
previously identified in the literature, prospective knowledge of the predictors identified in the 
study current can be used to refine existing treatment strategies.  The previous predictors 
described course of illness features for which there were no possible interventions, e.g., duration 
of illness, number of prior hospitalizations, and presence of comorbid psychiatric illness. These 
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variables identified those at risk for readmission, but they offered no direction for intervention.  
The other commonly identified previous predictors of readmission, weight at admission and 
discharge, were also beyond intervention because admission and discharge weight was strongly 
influenced by managed care policies and largely not at the discretion of treatment team decision 
making.  Due to the demographic or care environment driven nature of the previous predictors, 
there were no possible interventions that could be applied during the course of a treatment 
episode to alter patient status on the variables that were predicting readmission. Conversely, the 
currently identified predictors describe patient characteristics for which specific treatment 
interventions can be applied.  Prospective knowledge that body dissatisfaction and mood 
disorder symptoms are implicated in readmissions in the current care environment can be used to 
refine and augment treatment interventions that specifically and aggressively target theses 
symptoms at the inpatient level of care.  This knowledge could also focus treatment interventions 
at the partial hospital program level of care (the level of care most commonly recommended 
following inpatient treatment) to extend treatment work initiated at the inpatient level of care or 
in an effort to prevent hospitalization.  
Currently applied treatment strategies, such as cognitive behavioral treatment (CBT; e.g., 
Pike, 2003), dialectical behavior therapy (DBT; e.g., McCabe, LaVia, & Marcus, 2004, Telch & 
Agras, 2001, Telch, Agras & Linehan, 2000), and the use of movement/exercise could readily be 
adapted to more specifically address body dissatisfaction and mood symptoms, while 
simultaneously maintaining a focus on weight gain, as primary treatment targets at the intensive 
levels of care (inpatient and PHP).   The utility of concepts central to CBT, such as the 
identification of distorted thoughts, examination of evidence to support or refute beliefs, and 
thought restructuring techniques could be more specifically applied to thoughts and beliefs 
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associated with body dissatisfaction and mood symptoms at the inpatient and PHP levels of care.  
Currently, this work is typically done at the outpatient level of care when patients are closer to 
normal body weight and are therefore less cognitively impaired, better able to regulate emotion, 
and more responsive to psychopharmacologic interventions.  However, knowledge that the 
presence of body dissatisfaction and mood disorder symptoms predicts both that readmission is 
more likely to occur and that it will occur sooner, suggests the need to intervene earlier in the 
treatment episode.   
Interventions addressing body dissatisfaction and mood symptoms will need to be refined 
in order to be applied to patients who are at low body weight.   Careful consideration will need to 
be given to issues related to addressing body dissatisfaction in patients who remain at low body 
weight.  Because patients will remain underweight at the time of discharge from inpatient 
treatment, many of the traditional methods for addressing body image distortion and 
dissatisfaction are not applicable in low weight patients due to the cognitive impairments 
associated with low body weight (e.g., increased distortion, increased obsessionality, impaired 
emotion regulation). Moreover, interventions will need to take into account the fact that although 
patients are distressed by and dissatisfied with their current body weight, they are significantly 
under-weight and in need of continued weight gain.   Thus, because they have not yet achieved a 
normal body weight, increasing satisfaction with their current body may be an unhelpful and 
unrealistic goal, especially during the course of an inpatient stay.  Providing psychoeducation to 
patients and families highlighting the significance of body dissatisfaction and mood disorder 
symptoms, vis a vis readmission, may be a reasonable first step and may provide sufficient 
incentive to generate willingness to address these issues.   Increasing acceptance of the need to 
gain weight and the associated body changes, work that could be initiated during an inpatient 
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stay and continued as patients step down to PHP treatment, may be a more rational and attainable 
goal.     
Efforts to treat mood symptoms and body dissatisfaction through increasing acceptance 
could be addressed by combining aspects of DBT with a graduated and supervised exercise 
program.  Specific elements of DBT that would be useful are the DBT philosophical and 
treatment stance that simultaneously emphasizes acceptance and change and the use of the DBT 
Skills of core mindfulness and distress tolerance (Linehan, 1993), as detailed below.  
The DBT emphasis on dialectics, specifically the need for therapists to balance pulling 
for change with acceptance of the difficulty of changing, is useful in addressing the treatment 
ambivalence so characteristic of patients with AN.  Patient with AN frequently resist and resent 
treatment interventions, which may be experienced as intrusive, controlling and generally 
aversive.  DBT therapists are trained to use emotional, behavioral, and cognitive validation 
strategies that are designed to acknowledge that symptom behaviors serve a meaningful function 
and represent a legitimate effort to deal with life circumstances (acceptance).   However, DBT 
emphasizes the dialectic, which is that, although understandable, symptom behaviors also are 
associated with significant morbidity and mortality, and thus there is a need for behavior change.   
Core Mindfulness skills are central to DBT and are based on psychological and 
behavioral versions of meditation practices from Eastern spiritual training, mostly Zen 
Buddhism.  “Taking hold of one’s mind” by implementing strategies designed to develop a 
lifestyle of participation with awareness is the primary objective.   Also central to mindfulness is 
the concept of three primary states of mind: reasonable mind, emotion mind and wise mind. 
These states of mind provide a framework for decision making. Reasonable mind is rational and 
emphasizes the use of logic and factual information to evaluate and plan.  Reasonable mind is 
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devoid of emotion.  For example, the process of designing and building a bridge involves a series 
of reasonable mind decisions.  Emotion mind is when emotions override logical thought and 
control thinking.  Running into a burning building to save a loved one is an example of an 
emotion mind decision.  Practitioners of mindfulness recognize the necessity and usefulness of 
reasonable mind and emotion mind in particular situations, but strive to balance these two states 
of mind to achieve wise mind.  Wise mind is the integration of reasonable and emotion mind but, 
goes beyond a mere synthesis of the two to create a state of intuitive knowing.    
Mindfulness practice or “participation with awareness” is incompatible with the use of 
eating disorder behaviors to numb or avoid negative affect.  One cannot be simultaneously 
mindful and engage in behaviors that effectively work to decrease awareness of affect.  
Mindfulness resembles exposure therapy in that it involves increasing awareness of the mood 
states that patients with AN typically seek to avoid.  Patient with AN frequently are afraid or 
ashamed of their own thoughts and emotions.  Consequently, mindfulness is a critical skill 
because it emphasizes nonjudgmental acceptance of all moods and encourages observation and 
labeling of emotions.  Mindfulness is also useful for increasing awareness of and labeling of 
somatic cues (e.g., feelings of fullness, gastric distress) that contribute to body dissatisfaction in 
patients with AN and may serve as triggers for aberrant behaviors.  The “states of mind” 
conceptualization (i.e., emotion mind, reasonable mind, and wise mind) is also useful for 
targeting ambivalence in eating disorder patients because it promotes active and aware decision 
making.  Finally, it provides a framework for evaluating decisions and is useful for teaching the 
difference between thoughts and emotions and the inherent value of each.  
Distress tolerance skills are crisis survival strategies.  They are for use in situations that 
cannot be immediately changed.  Skills taught in this module are distraction, self-soothing, 
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strategies for improving the moment, and analysis of the pros and cons of tolerating the 
distressing situation. Since eating disorder behaviors such as restricting intake, binge eating, and 
purge behaviors enable patients with AN to avoid or tolerate uncomfortable, negative or 
overwhelming affect, distress tolerance skills are critical to help patients with AN tolerate 
negative emotions.    
There are situations specific to patients with AN for which distress tolerance skills are 
useful.  Treatment, especially inpatient treatment, is often experienced by patients with AN as 
aversive.  Weight gain in patients with AN is emotionally distressing and often physically 
uncomfortable.  Moreover, treatment is often foisted upon unwilling, if not involuntary patients, 
thus intensifying the perception of treatment as intrusive and unwarranted.   The distress 
tolerance skills offer strategies for short term use that enable patients to tolerate the distress 
caused by treatment in general and body dissatisfaction more specifically, until other adaptive 
strategies suitable for long term use can be integrated into daily life. 
A multi-pronged approach combining the above described therapeutic stance and skills 
with a graduated and supervised exercise program has not to our knowledge been described in 
the literature.  Given the psychological, motivational, and physiological difficulties associated 
with weight gain in patients with AN, considerable care must be taken so that the introduction of 
physical activity does not interfere with weight gain. The few studies examining the 
incorporation of exercise in the treatment of AN (Beumont, Arthur, Russell, & Touyz, 1994; 
Thien, Thomas, Markin & Birmingham, 2000; Vandereycken, Probst & Meermann, 1988) 
reported an increase in general and body satisfaction and an acceptable rate of continued weight 
gain.  The incorporation of exercise in the treatment of AN remains controversial and most 
treatment programs strongly caution against any form of energy expenditure.  However, because 
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efforts to prohibit exercise are rarely effective outside of the structure and near constant 
supervision of an inpatient unit and patients are compelled to exercise in response to distress 
associated with body dissatisfaction, there is rationale for prescribing an exercise plan that would 
address body dissatisfaction and mood symptoms, while not interfering with weight gain.  The 
exercise prescription would be individualized based on patient weight and other health related 
and psychological factors.  Moreover, the prescription would specify duration, intensity, and type 
of activity, and occur under supervision, ideally in a treatment setting. 
5.1.5 Social Work Implications 
The treatment implications discussed in the AN Treatment Implications section above are highly 
relevant to social workers. As previously noted, social workers are providing the majority of the 
mental health treatments delivered in this country (O’Neill, 1999, APA, 1997, Cohen, 2003) and 
as such are in a position to be treating and referring individuals with serious mental illnesses 
such as AN.  They, therefore, need to base their treatment decisions and interventions on the 
most up-to-date and best evidence available.  Knowledge of outcome predictors will inform the 
design of treatment interventions to better target specific aspects of illness or environment to 
enhance recovery efforts and improve outcome.  With such knowledge, clinicians working with 
patients who have AN would be better able to focus their clinical efforts on symptoms most 
likely to contribute to poor outcomes. Information from studies such as this can be applied to the 
ongoing refinement of diagnoses specific standards of care for use across treatment settings.   
Beyond the practice implications, however, social workers who function in advocacy and 
policy making roles have a responsibility to be monitoring our current system of mental health 
care delivery to ensure that all patients, especially those with serious and chronic mental illnesses 
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are receiving adequate services.  We have not yet achieved a system of mental health care 
delivery that balances the needs of patients who have serious mental illnesses with the 
undisputed cost and quality concerns that were inherent in our pre-managed care mental health 
care system. The implementation of certain managed care practices has resulted in some 
improved access for certain patients, specifically for those patients diagnosed with mild to 
moderate mental illness, who are typically treated in outpatient settings (Mauery, Vaquerano, 
Sethi, Jee, & Chimento, 2006).  However, it is the care needs of patients who may require longer 
length of stays in the most intensive (and expensive) levels of care, like some patients with AN 
and other serious mental illnesses, that conflict most notably with the managed care driven 
treatment environment and are the most at risk for poor outcomes in our current system of care 
delivery.  Findings such as those reported in this study, that specify predictors of poor outcome, 
could inform the design of more effective and efficient systems of care that take into account 
more precisely the special needs of vulnerable patient populations.   
This study, therefore, is consistent with the values and objectives of the social work 
profession, as outlined in the National Association of Social Workers’ Code of Ethics.  The 
Preamble to the Code of Ethics states “Fundamental to social work is attention to the 
environmental forces that create, contribute to, and address problems in living” 
(http://www.socialworkers.org/pubs/code/code.asp).  The mental health treatment environment 
has undergone fundamental change over the course of the last 15 years as a result of the 
widespread implementation of managed care practices.  Consequently, the manner in which 
treatment for AN and other serious mental illnesses is provided has been substantially affected.  
Concern regarding the effect of these changes on the outcomes of patients with AN (e.g., 
Weissman, Pettigrew, Sotsky, & Reigier, 2000; Williamson, Thaw, & Vernando-Sullivan, 2001; 
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Wiseman, Sunday, Klapper, Harris, & Halmi, 2000), and other serious mental illnesses (e.g., 
Huskamp, 1998; Wickizer & Lessler, 1998) has been reported in the literature, however research 
in this area is limited.  Further evaluation is needed to determine the extent to which the managed 
care treatment environment is affecting treatment outcomes. Further evaluation is also needed to 
determine if modifications to current managed care practices that limit access to and duration of 
care are necessary for specific populations.  A recent report issued by the U.S. Department of 
Health and Human Services reviewing the managed mental health care literature from 1990 - 
2005  concluded that “The paucity of such studies in the literature continues to restrict our ability 
to report on, or predict, which patients in which managed care settings may be harmed by benefit 
design limits or utilization techniques aimed at containing costs and improving appropriate use 
of the full spectrum of mental health and support services” (Mauery, Vaquerano, Sethi, Jee, & 
Chimento, 2006,  p. 24).    
The social work profession’s commitment to challenge social injustice, also as stated in 
the NASW Code of Ethics, is further support for the relevance of this study to the social work 
profession.  This principle states that “social workers pursue social change, particularly with and 
on behalf of vulnerable and oppressed individuals and groups of people…..Social workers strive 
to ensure access to needed information, services, and resources; …” 
(http://www.socialworkers.org/pubs/code/code.asp).  Individuals who require intensive and 
expensive mental health services may be vulnerable to negative outcomes in a managed care 
treatment environment that too strongly emphasizes cost containment, perhaps at the expense of 
providing necessary services.  Findings from studies such as this, that examine outcome in the 
current care environment, can bolster advocacy efforts on behalf of individual patients and 
groups of patients diagnosed with serious mental illness to ensure access to needed services and 
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resources.  Findings could also be used at a systems level to inform broader policy reform 
efforts.   
The effects of efforts to reduce costs by limiting access to and duration of care must be 
carefully monitored and evaluated by social workers and others in policy making and research 
roles to ensure that cost reduction efforts are in fact reducing costs and not inadvertently adding 
cost (Wickizer & Lessler, 1998) or merely shifting costs to individuals, families, and public 
sector health insurance plans.  Little is known about  non-health care costs such as out-of pocket 
expenses to patients and families, lost productivity, and care burden associated with AN (Simon, 
Schmidt & Pilling, 2005), although the consensus of professional opinion is that these costs are 
high.  Effectively and efficiently treating AN and other serious mental illnesses with fewer, but 
longer admissions may diminish personal costs such as suffering, lost income due to diminished 
functioning, and actual out-of-pocket expenses associated with a chronic course of AN.  
Moreover, they may reduce the overall costs to the mental health system that are generated by 
readmissions and other indicators of poor outcome. 
5.1.6 Strengths and Limitations of the Current Study  
In general, this study was limited by lack of information in several areas.  First, it would have 
been useful and interesting to know whether patients discharged from our treatment facility were 
readmitted elsewhere.  In this study, we had knowledge of only those patients who were 
readmitted to our program.  Knowledge of readmissions to other facilities presumably would 
have increased the validity of our conclusions.  Second, we did not have detailed information 
about what happened to patients who were treated outside of our treatment program between 
hospital admissions.  For example, we could not determine if patients participated in the 
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recommended post-inpatient treatment, the quality of their participation in ambulatory treatment, 
or if the ambulatory treatment was appropriate.  This information would be critical not only 
when assessing individual patient outcomes, but also useful in the evaluation of existing systems 
of care and barriers to accessing care.  Third, we had no information regarding the presence or 
quality of family and social support, factors that could influence relapse and readmission. Future 
research examining the extent to which family and social support affect readmission rates or the 
timing of readmission would be an important contribution to the AN treatment outcome 
database.  Fourth, we were unable to assess concepts related to patient motivation, such as 
commitment to treatment, engagement in treatment, and readiness for change.  Such information 
could potentially focus and inform future treatment modifications and should be obtained in 
future research in this area.   Fifth, although changes to the treatment environment were an 
impetus to this research, we had no pre-managed care comparison group, other than from the 
literature. Another short-coming related to the treatment environment was that we had no patient-
specific insurance information.   Future research examining information related to managed care 
pressure to discharge and refusals or delays in obtaining authorization for inpatient treatment will 
perhaps highlight more vividly pre- post-managed care differences and the influence of managed 
care on outcome.  Finally, although considerable attention was given to confirming the AN and 
comorbid diagnoses, we were unable to assess them using the gold-standard strategy of 
structured clinical interviews, leaving open the possibility that Axis I comorbid psychiatric 
diagnoses were not accurately diagnosed or detected. 
In spite of the significant limitations cited above, this work also exhibits significant 
strengths.   Most importantly, this study’s findings are based on a large sample of diagnosed, 
full-syndrome AN patients, a rarity in the treatment-outcome literature for this low-prevalence 
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condition.   Moreover, the study was conducted in the current care environment, about which 
very little information is available.  Moreover, because the data reported in this study were 
obtained as a part of routine clinical care, rather than a research study, the resulting sample may 
approximate more closely the population of persons with severe AN, thereby enhancing the 
generalizability of the findings.  Another strength of this study is that we comprehensively 
assessed numerous predictors.  The array of self-report, demographic, clinical, and treatment-
related predictors assessed in this study is more extensive than typically is seen in studies in this 
area.  Moreover, researchers rarely have evaluated whether self-reported AN psychopathology 
and depression predict negative outcomes for persons with AN who receive inpatient treatment, 
as doing so necessitates creating and sustaining an infrastructure to obtain this information.  
Another strength of the study is that we examined two criterion variables, both whether 
readmission occurred and time to readmission.  Predictors of these two outcome indices were 
strikingly similar, suggesting the robustness of the findings.  Finally, the study documents 
predictors of outcome over a 3 year period of time, which builds upon our prior work (Treat et 
al., under review) by extending the period of time during which outcome is assessed from several 
months after inpatient discharge to 3 years post discharge. 
5.2 CONCLUSIONS 
This study documented that the two strongest predictors of inpatient readmission for 
patients with AN in the current care environment are self-reported body dissatisfaction and 
clinician-diagnosed mood disorder at inpatient discharge.  These two variables together 
accounted for 12% of the variability in readmission status.  Although much research remains to 
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be done to explain the unaccounted for variance, this moderate-magnitude effect nonetheless 
warrants clinical attention and efforts to modify existing treatment strategies to target body 
dissatisfaction and mood disorder more precisely. 
Notably, the two primary predictors identified in this study differed from those most 
frequently identified in prior work, highlighting the importance of re-examining predictors of 
relapse and readmission after inpatient hospitalization in the current care environment of 
increasingly abbreviated inpatient stays.  Moreover, body dissatisfaction and mood disorder are 
far more amenable to intervention than previously identified predictors.  Although the previously 
discussed suggestions for augmenting existing treatment strategies will need to be carefully 
evaluated to determine their incremental utility, they represent a novel and potentially fruitful 
starting point for addressing the vexing problem of readmission in patients with AN. 
The present findings suggest the importance of further consideration of the extent to 
which the current care environment may exert a negative influence on treatment outcomes for 
patient populations diagnosed with serious mental illnesses.  As social workers, it is incumbent 
upon us to address the clinical, advocacy, policy development, and research issues resulting from 
the implementation of managed care practices to ensure that all patients with serious mental 
illnesses have access to effective and efficient mental health services.   
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